rellease ID

Doxis Named a Leader in the IDC MarketScape: Worldwide Intelligent Content Services 2026 Vendor Assessment

Fri, 06 Nov 2026 20:42:00 +0700

Doxis, The Document Intelligence Company, today announced it has been named a Leader in the IDC MarketScape: Worldwide Intelligent Content Services 2026 Vendor Assessment

*IDC MarketScape notes Doxis' depth of platform, deployment speed, as well as architecture and interoperability as strengths.

*"For organizations looking to consolidate point solutions and address the full content life cycle - ECM, CCM, and IDP - within a single platform, Doxis is a good fit," the IDC MarketScape notes.

*IDC MarketScape evaluated 17 intelligent content services vendors on their capabilities and strategies.

BONN, Germany, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Doxis, The Document Intelligence Company, today announced it has been named a Leader in the IDC MarketScape: Worldwide Intelligent Content Services 2026 Vendor Assessment*.

We believe the IDC MarketScape arrives at a pivotal time as enterprises are moving AI out of the pilot stage and embedding it into core content-intensive business processes. "Content earns the label 'intelligent' when it stops being merely stored and retrieved and becomes the context layer that AI and automation depend on to reason, retrieve, and act reliably," says Amy Machado, Research Director, Content and Knowledge Discovery Strategies, IDC.

As we see it, Doxis is recognized as a Leader because it provides that context layer for AI, empowering enterprise customers to securely manage and act on high volumes of documents from capture through archiving on one unified AI-first platform, instead of across separate systems.

"AI pilots can demonstrate what's possible, but running AI across billions of business documents in a secure, repeatable and trustworthy way is a different challenge," says Dr. John Bates, CEO of Doxis. He continues: "It demands a scalable architecture, reliable processes, deep business context and governance that works at every step. We've built Doxis to bring those capabilities together in one trusted Document Intelligence platform. We're proud to be recognized as a Leader in the IDC MarketScape as more enterprises seek to bolster productivity and efficiency through Document Intelligence."

Read the IDC MarketScape excerpt about Doxis here.

Platform depth, interoperability and fast time-to-value of Doxis

From our view, Doxis was named a Leader based on strengths in the following areas:

Depth of platform: Doxis is an AI-first platform that unites enterprise content management (ECM), process automation, intelligent document processing (IDP), and intelligent communications to deliver document intelligence across the entire document lifecycle.

Rapid time-to-value: Enterprise customers are typically able to deploy Doxis in weeks rather than months for a quick time-to-value.

Architecture and interoperability: Doxis offers deep integrations with leading systems, including SAP S/4HANA, SAP SuccessFactors, Salesforce, Microsoft 365, ServiceNow and Workday, and provides more than 150 third-party connectors.

IDC MarketScape recognition follows continued rapid growth period for Doxis

Doxis' recognition as a Leader in the IDC MarketScape follows a period of platform investment and rapid business growth. Over the past 12 months, Doxis acquired customer communication and experience management specialist Metaforce and launched Doxis AI.dp to enhance its intelligent document processing capabilities. Doxis also significantly expanded its portfolio of SAP certifications and solutions for document-centric SAP processes to help customers accelerate their Clean Core strategy - most recently to automate procurement and invoice processing across SAP ERP and SAP S/4HANA environments.

*IDC MarketScape: Worldwide Intelligent Content Services 2026 Vendor Assessment, Amy Machado, IDC #US54137426

Axi opens up pre-IPO trading opportunities on OpenAI and Anthropic

Fri, 06 Nov 2026 20:38:00 +0700

New perpetual futures contracts give traders access to price movements linked to two of the world's most prominent artificial intelligence companies ahead of their anticipated public market debuts

SYDNEY, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Axi, a global online FX and CFD broker, has introduced pre-IPO perpetual futures contracts linked to OpenAI and Anthropic, giving traders the opportunity to take positions on the price movements of two of the world's most closely watched artificial intelligence companies before their anticipated stock market listings.

The launch comes as the race to bring leading AI companies to the public markets gathers momentum. Anthropic, the company behind AI assistant Claude, filed for an initial public offering (IPO) on Oct. 26 2026, with plans to list on the Nasdaq under the ticker symbol ANT. Meanwhile, OpenAI, the developer of ChatGPT, has also been pursuing a potential public listing, with its longer-term IPO plans attracting significant market attention.

As anticipation builds around the future valuations of both companies, Axi's new offering provides an alternative way for traders to gain exposure to their evolving market valuations without waiting for a traditional stock market listing.

Through the new contracts, traders can take either long or short positions, allowing them to speculate on potential upward or downward price movements. The perpetual futures are available to trade 24 hours a day, seven days a week, including weekends, offering flexibility beyond conventional exchange trading hours.

The contracts also provide access to leverage of up to 25:1, enabling traders to take positions with a smaller initial margin relative to their overall market exposure. As perpetual futures, the contracts do not require traders to own shares in either company or hold an underlying equity position.

The introduction of OpenAI and Anthropic contracts further expands the range of opportunities available through Axi, reflecting the growing intersection between financial markets, emerging technologies and the global AI industry.

About Axi

Axi is a global online trading broker providing retail and professional traders with access to forex, stocks, indices, commodities. Through its trading platforms, educational resources, and market analysis tools, Axi helps traders navigate global financial markets with confidence.

Promoted by AxiTrader LLC. Trading carries a high risk of investment loss. This content may not be available in your region. Not intended as investment advice.

The Metals Company Announces Third Quarter 2026 Corporate Update Conference Call for Thursday, November 12, 2026

Fri, 06 Nov 2026 20:35:00 +0700

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) ("TMC" or the "Company"), a leading developer of the world's largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Thursday, November 12, 2026, to provide an update on third quarter 2026 financial results and recent corporate developments.

Third Quarter 2026 Conference Call Details

Date: Thursday, November 12, 2026

Time: 4:30 p.m. ET

Audio-only Dial-in: Register Here

Virtual webcast with slides: Register Here

The virtual webcast will be available for replay in the 'Investors' tab of the Company's website under 'Investors' > 'Media' > 'Events and Presentations', approximately two hours after the event.

About The Metals Company

The Metals Company is a developer of lower-impact critical metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for energy, defense, manufacturing and infrastructure with net positive impacts compared to conventional production routes and (2) trace, recover and recycle the metals we supply to help create a metal commons that can be used in perpetuity. The Company has conducted more than a decade of research into the environmental and social impacts of offshore nodule collection and onshore processing. More information is available at www.metals.co.

Contacts

Media | media@metals.co

Investors | investors@metals.co

Physical AI and Manufacturing Company Nemi to Go Public at a $400 Million Pre-Money Equity Value Through Business Combination with BHAV Acquisition Corp

Fri, 06 Nov 2026 19:29:00 +0700

Nemi Is Developing its Large Manufacturing Model, an AI-Powered Platform Designed to Automate Product Design, Engineering and Manufacturing End-to-End While Reducing Costs and Lead Times

Nemi Operates 300,000+ Square Feet of Manufacturing Operations, Serving Over 50 Enterprise Customers Across Aerospace, Defense and Automotive Markets Worldwide

STAFFORD, Texas and PISCATAWAY, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nemi Corp. ("Nemi" or the "Company"), a Physical AI and Manufacturing-as-a-Service company building the Large Manufacturing Model ("LMM"), and BHAV Acquisition Corp (Nasdaq: BHAV) ("BHAV"), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement (the "Business Combination Agreement", and the transaction, the "Business Combination").

The Business Combination is expected to close in the first quarter of 2027, subject to approval by BHAV's and Nemi's shareholders, regulatory approvals and other customary closing conditions. Following completion of the proposed Business Combination, Nemi will be the listed parent company and expects its Class A common stock to trade on The Nasdaq Stock Market under the ticker symbol "NEMI".

A Manufacturer First, Building AI Where Parts Are Made

Nemi operates more than 300,000 square feet of manufacturing space in India. The Company makes precision metal parts, tooling, electronics, batteries, motors, plastics and complex assemblies, and holds AS9100D and ISO 9001 certifications. Nemi sells this capacity to enterprise customers as Manufacturing-as-a-Service ("MaaS") and also operates an electric-vehicle business. In FY2025, Nemi's MaaS business grew revenue 38% year-over-year with gross margins of 32.5%.

The LMM is a comprehensive stack for automating all aspects of hardware manufacturing: Anvil for design and engineering, Orion for factory operations and robotics, and Atlas for commercial and after-sales work.

Nemi is led by Founder and Chief Executive Officer Anirudh Ravi Narayanan, who brings extensive experience across aerospace and defense engineering, advanced manufacturing and business strategy. Prior to founding Nemi, Mr. Narayanan held roles at McKinsey & Company, where he worked in its Digital and Industrial practices, and previously held engineering positions in the aerospace and defense electronics industry. He holds an MBA from the Yale School of Management and an engineering degree from Rose-Hulman Institute of Technology.

Engineering Today, the Factory Floor Next

Anvil turns an engineering brief into CAD, electronics design, simulation and a released bill of materials. On more than 35 customer and internal programs over the past 12 months, Nemi measured design work finishing about three times faster with about one-third of the engineers, compared with its pre-LMM baselines for similar work. Together, that is roughly nine times the design output per engineer.

Results on recent programs, compared with management's estimates of typical industry timelines:

A full electric-vehicle platform for Nemi's own EV business, taken from concept to production-ready in 9 months against a typical 18-month period.

A complete drone powertrain (battery, motor, controller and ground unit) for a Tier-1 defense manufacturer, delivered in 4 months against a typical 16-month period, at about 20% lower parts cost.

A production line for a consumer-appliance maker stood up in 5 weeks with no tooling cost.

A flight-critical aerospace part cut from 7 hours to 3 hours per job while holding a 10-to-15 micron tolerance.

Nemi's first market is high-product mix, low-volume programs in aerospace, defense and other demanding industrial sectors, where engineering is a large share of cost. Next, the Company plans to automate its factory floor. Its digital-twin ERP is already deployed, factory orchestration is in pilot, and low-cost robotics are in development. Nemi plans to implement and stress test each step in its own plants before using it in manufacturers it acquires.

Growing Commercial Momentum Across High-Value Manufacturing Markets

As of October 14, 2026, Nemi had more than $14 million of open purchase orders from 16 customers, subject to the realization of certain contractual milestones. Current customers have also signed non-binding letters of intent ("LOIs") with an indicative value of over $100 million of revenue for Nemi through 2028.

Nemi serves more than 50 enterprise customers across its manufacturing and electric-vehicle businesses. Its customers include defense, aerospace and space organizations in India, directly or through partners, as well as automotive manufacturers. Nemi's existing shareholders include Musashi Seimitsu Industry Co., Ltd., a listed Japanese automotive components maker.

In 2025, consolidated gross margin rose to 17.7% from 3.1% in 2024.

Growth Plan and Operating Target

Nemi plans to scale by adding factory capacity for existing customer programs and by acquiring traditional manufacturers, then deploying the LMM in them. Nemi has a robust pipeline of prospective targets, though no definitive agreements have been signed to date.

Management is targeting approximately $120 million of operating annualized revenue run-rate ("Operating ARR") for the quarter ending twelve months after closing, up from approximately $20 million expected at closing. The target reflects management's planned manufacturing capacity expansion, anticipated customer demand and contributions from prospective acquisitions.

"We believe Physical AI is going to bring about the next industrial revolution," said Anirudh Ravi Narayanan, Chief Executive Officer of Nemi. "Our goal, stated simply, is to do for hardware what LLMs did for software. Hardware is hard. Its data is mostly proprietary and closed, so whoever intends to automate it has to be inside the factory. That is why we are a manufacturer first: each part we design and build becomes data for the next one. To gather data fast, we have to grow fast. Every manufacturing company will eventually run on AI. We want to help them get there."

Transaction Overview

The Business Combination Agreement sets Nemi's pre-money equity value at $400 million, or 40,000,000 shares at $10.00 per share. That fixed number covers all shares issued for Nemi's existing equity, including outstanding equity awards and the securities issued in Nemi's pre-closing financing. The consideration is entirely in stock, and there is no earnout.

Nemi is targeting to raise $50 million in a private investment in public equity (the "PIPE") at $10.00 per share. Assuming the full amount of the PIPE is raised and no redemptions by BHAV's public shareholders, the proposed Business Combination is expected to provide approximately $142.5 million of cash at closing from BHAV's $100 million trust account and the PIPE, after estimated expenses.

The proposed Business Combination includes a minimum available closing cash condition of $30 million, which the parties may waive; available cash includes funds held in BHAV's trust account after redemptions and the proceeds of the PIPE and the pre-closing financing.

Nemi intends to use the proceeds from the proposed Business Combination to expand factory capacity, acquire manufacturers that already serve its markets, continue developing the LMM and Phase 2 robotics toward greater levels of automation and fund working capital.

The boards of directors of Nemi and BHAV have unanimously approved the transaction, and BHAV's board has received a fairness opinion. BHAV's sponsor has agreed to vote its shares in favor of the proposed Business Combination and not to redeem them. Closing is expected in the first quarter of 2027, subject to approval by BHAV's and Nemi's shareholders, effectiveness of a registration statement on Form S-4, regulatory approvals and other customary conditions. Additional information about the proposed Business Combination, including a copy of the Business Combination Agreement and investor presentation, will be provided in a Current Report on Form 8-K to be filed by BHAV with the U.S. Securities and Exchange Commission (the "SEC") and available at www.sec.gov.

BHAV's Chief Executive Officer and Director Giri Devanur added, "Nemi is building Physical AI from inside the factory. With real manufacturing operations, enterprise customers and proprietary data, we believe Nemi has the foundation to transform how products are designed and manufactured."

Advisors

Cantor Fitzgerald & Co. is serving as sole placement agent and capital markets advisor to Nemi.

Maxim Group LLC is serving as capital markets advisor to BHAV.

Loeb & Loeb LLP is serving as legal counsel to Nemi.

Mitchell Silberberg & Knupp LLP is serving as legal counsel to BHAV.

About Nemi Corp.

Nemi is a Physical AI and Manufacturing-as-a-Service company focused on transforming how physical products are designed, engineered and manufactured. Through its proprietary Large Manufacturing Model, Nemi is developing an integrated AI platform designed to automate the product lifecycle, from initial concept and engineering through manufacturing, quality control and delivery. The Company operates manufacturing facilities serving enterprise customers across the aerospace, defense, automotive and industrial sectors, leveraging its own operations to develop, deploy and continuously improve its AI capabilities. By combining real-world manufacturing expertise with AI-driven automation, Nemi aims to reduce production costs, accelerate development timelines and improve manufacturing efficiency at scale. For more information, visit https://nemilmm.com/.

About BHAV Acquisition Corp

BHAV Acquisition Corp (Nasdaq: BHAV, BHAVU, BHAVR) is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. BHAV completed its $100 million initial public offering in March 2026. It is led by Giri Devanur, its Chief Executive Officer and a director, who is also the sole managing member of its sponsor, BHAV Partners LLC. Mr. Devanur has led three companies to Nasdaq listings: AMERI Holdings (2017), reAlpha Tech Corp. (2023) and BHAV (2026). For more information, visit https://bhavspac.com/.

Notes on Metrics and Other Disclosures

Customer counts, LOIs, management pipeline, program counts, design-productivity measurements, program results and Operating ARR are based on unaudited management records and have not been independently verified. LOIs are non-binding and may not become orders or revenue. Typical industry timelines are management's estimates for comparable programs. MaaS growth and margin come from the financial statements of the MaaS subsidiary used in the audited consolidation and include sales to other Nemi companies. Amounts from the audited U.S. GAAP financial statements are shown in U.S. dollars as presented in those statements; other U.S. dollar amounts are converted from Indian rupees at 95.98 per US$1.00 (FBIL reference rate, September 30, 2026).

LMM tools (Anvil, Orion and Atlas) use the third-party AI models best suited to their respective tasks. Nemi does not develop its own foundation models; the LMM is named by analogy to large language models.

Open purchase orders are orders received but not yet delivered and invoiced, at October 14, 2026, net of invoicing to September 30, 2026, as disclosed in Note 2(d) to the audited consolidated financial statements (the customer count is from Nemi's purchase-order registers); they include blanket purchase orders from a fleet customer, against which releases are issued. The LOIs are non-binding; their stated values are indicative potential sales through 2028.

The audited financial information is taken from the consolidated financial statements of BNC Motors Pvt. Ltd. ("BNC Motors") and its subsidiaries, Nemi's Indian operating group (which was Nemi's sole operating group during those periods), for the years ended December 31, 2025 and 2024, prepared under U.S. GAAP.

Operating ARR is the latest quarter's external revenue multiplied by 4, excluding intercompany revenue; it is a run-rate, not contracted revenue or a U.S. GAAP measure. Operating ARR for the quarter ended September 30, 2026 was approximately $3.7 million, based on provisional, unaudited accounts. The approximately $20 million expected at closing assumes $50 million of pre-closing financing to add the working capital and capacity needed to execute the demand pipeline. The $120 million target assumes approximately $100 million of funding before and at closing, planned capacity additions to ramp up to customer demand and about $30 million of Operating ARR from acquisitions that have not yet been committed. Both the closing estimate and the target are management estimates, not forecasts.

On closing, shares held by Nemi's founder and his affiliates, and BHAV sponsor shares allocated to Giri Devanur, will become Nemi Corp. Class B common stock, which carries ten votes per share, has the same economic rights as Class A common stock and converts into Class A common stock on a one-for-one basis. All other Nemi shareholders, and BHAV shareholders who do not redeem, will receive Class A common stock. Closing is also subject to a minimum available closing cash condition of $30 million, which the parties may waive; available cash includes the funds held in BHAV's trust account after redemptions and the proceeds of the PIPE and the pre-closing financing.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the Business Combination between Nemi and BHAV. The safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 is not available for forward-looking statements made in connection with the Business Combination, and neither Nemi nor BHAV relies on it. Forward-looking statements include statements about the expected timing, structure and completion of the Business Combination; the satisfaction of closing conditions; the listing of Nemi Corp.'s Class A common stock on Nasdaq; the cash expected to be available at closing, including after redemptions; the expected use of proceeds; Nemi's plans, strategy and technology and product roadmap, including the LMM and Phase 2 robotics; Nemi's planned capacity expansion and acquisitions; the PIPE financing or any other financing; Nemi's estimate of Operating ARR at closing and its target of $120 million of Operating ARR for the quarter ending twelve months after closing, and the funding, capacity and acquisition assumptions underlying them; the expected composition of Nemi Corp.'s board and management; and the expected benefits of the Business Combination. Words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "should," "target," "will" and "would," and similar expressions, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.

These statements are based on the current expectations of Nemi's and BHAV's management and are not predictions of actual performance. They are subject to risks and uncertainties, many beyond the parties' control, that could cause actual results to differ materially, including: the occurrence of any event, change or other circumstance that could give rise to the termination of the Business Combination Agreement, including if the Business Combination is not completed by June 20, 2027 (or any extended date); the failure to obtain the approval of BHAV's shareholders or Nemi's shareholders, required regulatory approvals or to satisfy other closing conditions, including the effectiveness of the registration statement and the $30 million minimum available closing cash condition; the level of redemptions by BHAV's public shareholders; Nemi's ability to complete the PIPE financing or obtain other financing before or after closing on acceptable terms, or at all; the conditions that raised substantial doubt about the ability of BNC Motors and its subsidiaries to continue as a going concern, a doubt that management concluded its plans alleviate, as described in their audited consolidated financial statements; the completion of the remaining steps of Nemi's reorganization of BNC Motors, including Indian regulatory filings, and Nemi's ability to acquire the BNC Motors shares it does not hold; the interests of BHAV's sponsor, directors and officers in the Business Combination, which may differ from those of BHAV's public shareholders; the ability to obtain or maintain the listing of Nemi Corp.'s securities on Nasdaq; the outcome of any legal proceedings relating to the Business Combination; Nemi's limited operating history at its current scale, its history of losses and its ability to manage growth; Nemi's dependence on a limited number of customers and suppliers, and the risk that open purchase orders are delayed or cancelled or that letters of intent do not convert into orders; Nemi's ability to complete and integrate acquisitions; the concentration of Nemi's operations and assets in India and related economic, political, regulatory, currency and tax risks, including compliance with Indian foreign-investment rules; the risk that Nemi's technology, including the LMM, does not perform as expected, and Nemi's ability to protect its intellectual property; competition, including from better-capitalized companies; export-control, defense and security requirements; the effects of Nemi Corp.'s dual-class share structure and the voting control of Nemi's founder; dilution; the costs of the Business Combination and of operating as a public company; and the other risks to be described under "Risk Factors" in the registration statement on Form S-4 that will be filed in connection with the proposed Business Combination and in BHAV's filings with the SEC. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such statements will be achieved. Except as required by law, neither Nemi nor BHAV undertakes any duty to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Additional Information and Where to Find It

In connection with the Business Combination, Nemi intends to file with the SEC a registration statement on Form S-4 (as amended, the "Registration Statement"), which will include a preliminary proxy statement of BHAV and a preliminary prospectus of Nemi relating to the securities to be issued in the Business Combination. After the Registration Statement is declared effective, BHAV will mail a definitive proxy statement/prospectus and other relevant documents to its shareholders as of the record date established for voting on the Business Combination at an extraordinary general meeting of BHAV's shareholders. This press release is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Nemi or BHAV may file with the SEC. BHAV'S SHAREHOLDERS AND OTHER INTERESTED PERSONS ARE URGED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, THE PRELIMINARY PROXY STATEMENT/PROSPECTUS AND ANY AMENDMENTS TO THEM, THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS FILED IN CONNECTION WITH THE BUSINESS COMBINATION, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NEMI, BHAV AND THE BUSINESS COMBINATION. Shareholders will be able to obtain free copies of these documents, when available, at the SEC's website, www.sec.gov, or by directing a request to BHAV Acquisition Corp, 255 Old New Brunswick Rd., Suite N210, Piscataway, NJ 08854, Attention: chaitanya@bhavspac.com.

Participants in the Solicitation

BHAV, Nemi and their respective directors and executive officers may be deemed participants in the solicitation of proxies from BHAV's shareholders in connection with the Business Combination. Information about BHAV's directors and executive officers and their ownership of BHAV securities is set out in BHAV's final prospectus for its initial public offering, dated March 18, 2026 and filed with the SEC on March 20, 2026, and in BHAV's subsequent filings with the SEC. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Registration Statement and the proxy statement/prospectus when available. Free copies of these documents may be obtained as described above.

No Offer or Solicitation

This press release is not a proxy statement or a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination, and it does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE TRANSACTIONS DESCRIBED IN THIS PRESS RELEASE, PASSED UPON THE MERITS OR FAIRNESS OF THE BUSINESS COMBINATION OR RELATED TRANSACTIONS, OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS PRESS RELEASE. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.

Physical AI and Manufacturing Company Nemi to Go Public at a $400 Million Pre-Money Equity Value Through Business Combination with BHAV Acquisition Corp

Fri, 06 Nov 2026 19:29:00 +0700

Nemi Is Developing its Large Manufacturing Model, an AI-Powered Platform Designed to Automate Product Design, Engineering and Manufacturing End-to-End While Reducing Costs and Lead Times

Nemi Operates 300,000+ Square Feet of Manufacturing Operations, Serving Over 50 Enterprise Customers Across Aerospace, Defense and Automotive Markets Worldwide

A Manufacturer First, Building AI Where Parts Are Made

Engineering Today, the Factory Floor Next

Results on recent programs, compared with management's estimates of typical industry timelines:

A full electric-vehicle platform for Nemi's own EV business, taken from concept to production-ready in 9 months against a typical 18-month period.

A complete drone powertrain (battery, motor, controller and ground unit) for a Tier-1 defense manufacturer, delivered in 4 months against a typical 16-month period, at about 20% lower parts cost.

A production line for a consumer-appliance maker stood up in 5 weeks with no tooling cost.

A flight-critical aerospace part cut from 7 hours to 3 hours per job while holding a 10-to-15 micron tolerance.

Growing Commercial Momentum Across High-Value Manufacturing Markets

In 2025, consolidated gross margin rose to 17.7% from 3.1% in 2024.

Growth Plan and Operating Target

Transaction Overview

Advisors

Cantor Fitzgerald & Co. is serving as sole placement agent and capital markets advisor to Nemi.

Maxim Group LLC is serving as capital markets advisor to BHAV.

Loeb & Loeb LLP is serving as legal counsel to Nemi.

Mitchell Silberberg & Knupp LLP is serving as legal counsel to BHAV.

About Nemi Corp.

About BHAV Acquisition Corp

Notes on Metrics and Other Disclosures

Forward-Looking Statements

Additional Information and Where to Find It

Participants in the Solicitation

No Offer or Solicitation

Bitget Introduces Open Custody Network, Redefining the Relationship Between Custody and Trading

Fri, 06 Nov 2026 19:25:00 +0700

VICTORIA, Seychelles, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), has announced the launch of the Open Custody Network (OCN), a new network connecting banks and institutional-grade custodians with Bitget's trading infrastructure for all eligible users.

The initiative addresses a longstanding structural characteristic of the cryptocurrency exchange industry: the concentration of asset custody and trading activities within a single platform. Under the traditional centralized exchange model, users typically transfer their assets to an exchange to access the trading capabilities, concentrating custody and execution within the same venue.

Bitget OCN aims to address this shift by uniting custody independence, banking and institutional-grade security, integrated exchange trading, capital efficiency, and connected liquidity. Through Bitget OCN, users can maintain custody of their assets with participating external providers while accessing trading opportunities on Bitget, without requiring the underlying assets to be held directly in exchange custody. It also aims to provide traders with a more integrated experience, lower barriers to entry for everyone, and more equitable access to financial services.

OCN connects independent custody with Bitget's spot, margin, and futures markets through asset mirroring, allowing eligible users to trade while keeping assets with their selected provider. For market makers, asset managers, and other institutions, the solutions offer a practical way to manage custody concentration risk while putting externally held assets to work across trading strategies. The result is greater custody flexibility and the ability to deploy externally held assets across trading strategies.

"We challenge the assumption that users must place their assets in an exchange's custody to access its trading capabilities," said Gracy Chen, CEO of Bitget. "Our proposition, 'Assets in Bank, Tradings on Bitget.', puts custody choice at the centre of that approach. For the first time, users can leverage world-class liquidity and capital efficiency with lower barriers and zero compromise on custody."

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

Global Higher Education Forum Highlights Hong Kong's Strategic Vision as International Talent Hub

Fri, 06 Nov 2026 19:21:00 +0700

Pictured at the World Class University Presidents Forum 2026 in Hong Kong are (from left) HKUST President, Professor Nancy Ip; HKSAR's Acting Chief Executive, Mr Chan Kwok-ki; the Minister of Education, Mr Huai Jinpeng; HKSAR's Secretary for Education, Dr Choi Yuk-lin; and HKUST Council Chairman, Professor Harry Shum.

Source: Information Services Department, Hong Kong SAR Government

HONG KONG SAR - Media OutReach Newswire - 5 November 2026 - Education leaders from around the world gathered in Hong Kong for the World Class University Presidents Forum 2026 (November 4-5), further enhancing the city's prestige as a global hub for higher education and promoting academic collaboration and exchanges.

University presidents, renowned scholars and international education leaders representing more than one-third of the world's top 50 universities joined the Forum, which was held at the Hong Kong University of Science and Technology (HKUST). They discussed key issues such as talent cultivation in the intelligent age, technology and innovation driving the future economy, and universities' response to major global challenges.

Speaking at the opening ceremony (November 4), Chan Kwok-ki, Acting Chief Executive of the Hong Kong Special Administrative Region (HKSAR), said the Forum's theme, "Higher Education Reimagined: Innovating for the Future" reflects the current global environment.

"We live in an age of rapid technological change, systemic economic shifts, and unprecedented global challenges," Mr Chan said. "In this transformative landscape, universities are no longer just communities of learning and skills development. They are engines of innovation, guardians of truth, and architects of our collective future."

Mr Chan noted that higher education has always been a vital pillar of Hong Kong's success, with the city being home to five universities that are ranked among the world's top 100. Also, the latest QS World University Rankings: Asia 2027 (November 3), listed five Hong Kong universities in Asia's top 10, and three in Asia's top five, further demonstrating the strength of Hong Kong's higher education system.

"This is not by chance," Mr Chan said. "It is the result of sustained government investment, clear policy direction and the hard work of our universities."

Serving as a bridge between East and West, Hong Kong offers a fertile ecosystem characterised by internationalisation and diversification, which brings global talent together to address shared global challenges.

"Alongside signature international events such as the Asia-Pacific Association for International Education (APAIE) Conference and Exhibition held in February, the World Class University Presidents Forum 2026 forms part of a strategic series of signature initiatives promoting the 'Study in Hong Kong' brand worldwide, underscoring the city's role as a key driver shaping the future of global higher education," said Dr Choi Yuk-lin, the Secretary for Education of the HKSAR.

Dr Choi stressed that Hong Kong's educational future is taking concrete physical shape through the development of the Northern Metropolis University Town.

Under the "One town, Five elements" framework, the HKSAR Government is building a holistic campus ecosystem integrating higher education, advanced research, market innovation, vibrant living spaces, and top-tier talent.

"Positioned at the gateway to the Chinese Mainland, the University Town will foster deep Industry-Academia-Research integration, linking academic research directly with industry capabilities to serve national development under the 15th Five-Year Plan," Dr Choi said.

Several heavyweight interuniversity co-operation signing ceremonies were also held during the Forum. These included a Memorandum of Understanding (MOU) on deepening collaboration between Central South University and Monash University; an MOU between Zhejiang University and the HKUST on the establishment of a joint innovation centre; a Trilateral Joint Seed Fund agreement among the University of Warwick, Nanyang Technological University, and Shanghai Jiao Tong University; as well as a student exchange agreement between Trinity College Dublin and Nanjing University, marking a new milestone in global higher education and research collaborative innovation.

"Assembling such a distinguished constellation of global academic leadership strongly reaffirms Hong Kong's standing as an international education hub and significantly enhances the city's discourse power in the global educational arena," Dr Choi said.

The issuer is solely responsible for the content of this announcement.

Hashtags: #HongKong #BrandHongKong #Education #Talent #University

https://www.brandhk.gov.hk/

https://www.linkedin.com/company/brand-hong-kong/

https://x.com/Brand_HK/

https://www.facebook.com/brandhk.isd

https://www.instagram.com/brandhongkong

Ingredion Incorporated Reports Third Quarter 2026 Results

Fri, 06 Nov 2026 19:01:00 +0700

*T&HS delivered its 10th consecutive quarter of net sales volume growth, with share gains in strategic categories, including continued clean label growth globally

*Third quarter 2026 reported and adjusted* operating income both decreased 19% compared to the third quarter 2025

*Third quarter 2026 reported and adjusted diluted EPS were $2.23 and $2.28, compared with $2.61 and $2.75 in the third quarter 2025

*Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70

WESTCHESTER, Ill., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its third quarter 2026 results.

"Our third quarter results fell short of our expectations, largely due to Argo's slower than anticipated financial recovery, with incremental pressure from higher input costs and consumer softness," said Jim Zallie, chairman, president and CEO of Ingredion. "While production at Argo remained stable for a second consecutive quarter and inventories are largely rebuilt, high manufacturing costs coupled with softer food and beverage demand impacted profitable volume growth. With plant reliability improved, our focus has shifted to sustainably lowering operating costs and improving volume growth. While we expect these actions to improve earnings, the recovery is taking longer than we expected."

"For Texture & Healthful Solutions, net sales volume growth was a bright spot again this quarter. Volume grew for the tenth consecutive quarter, supported by continued strong demand for clean label globally as customers reformulate for simpler labels, affordability and nutrition. However, higher tapioca costs and manufacturing input cost inflation negatively impacted profit growth in the segment. In Food & Industrial Ingredients-LATAM, stronger volume from brewing and beverage customers in Mexico and Brazil was offset by foreign exchange impacts from a stronger Mexican peso and the impact to our Andean operations from the August earthquake in Colombia."

"As a result, we are lowering our full-year outlook, primarily to reflect the slower earnings recovery in Food & Industrial Ingredients?U.S./CAN, along with the impacts of higher input costs and softer demand."

"Looking ahead, we are taking action to improve financial performance through operating cost discipline and spend management, while we continue to invest in our specialty growth platforms. As we progress the integration planning for the pending acquisition of Tate & Lyle, we are building the foundation for an even stronger company with greater opportunities for growth, innovation and shareholder value creation in 2027 and beyond."

*Reported results are in accordance with U.S. generally accepted accounting principles "GAAP." Adjusted financial measures are non-GAAP financial measures. See "II. Non-GAAP Information" in the Supplemental Financial Information that follows the Condensed Consolidated Financial Statements for a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures.

Diluted Earnings Per Share (EPS)

3Q25		3Q26
Reported Diluted EPS	$	2.61	$	2.23
Acquisition/integration costs, net		-		0.09
Impairment charges		-		0.08
Restructuring costs, net		0.05		(0.18	)
Tax items and other matters		0.09		0.06
Adjusted Diluted EPS**	$	2.75	$	2.28

Factors affecting changes in Reported and Adjusted Diluted EPS

	3Q26
Total items affecting adjusted diluted EPS**	(0.47	)
Total operating items	(0.54	)
Margin	(0.72	)
Volume	0.05
Foreign exchange	0.04
Other income	0.09
Total non-operating items	0.07
Financing costs	(0.03	)
Non-controlling interests	0.02
Tax rate	--
Shares outstanding	0.06
Other non-operating income	0.02

** Totals may not sum or recalculate due to rounding

Business Review

Total Ingredion

Net Sales

$ in millions	2025	FX Impact	Volume	Pakistan Volume*	Price Mix	2026	Change	Change excl. FX
Third Quarter	1,816	26	21	(65)	(6)	1,792	(1%)	(3%)
Year-to-Date	5,462	95	9	(65)	(67)	5,434	(1%)	(2%)

*Represents loss of volume due to the sale of the majority stake in our Pakistan business

Third quarter net sales decreased 1%, primarily reflecting the sale of the majority stake in our Pakistan business. Excluding results of the Pakistan business, net sales increased 2%, driven by favorable foreign exchange and by higher volumes in F&II?LATAM and T&HS.

Reported Operating Income

$ in millions	2025	FX Impact	Business Drivers	Restructuring/ Impairment	Other	2026	Change	Change excl. FX
Third Quarter	249	4	(52)	17	(17)	201	(19%)	(21%)
Year-to-Date	796	15	(139)	(29)	(51)	592	(26%)	(28%)

Adjusted Operating Income

$ in millions	2025	FX Impact	Business Drivers	2026	Change	Change excl. FX
Third Quarter	254	4	(52)	206	(19%)	(21%)
Year-to-Date	800	15	(139)	676	(16%)	(18%)

Third quarter reported and adjusted operating income were $201 million and $206 million, respectively. The $5 million difference between reported and adjusted operating income reflects acquisition-related costs, impairment charges and Argo thermal event costs, largely offset by a net restructuring benefit. Excluding foreign exchange translation impacts, reported and adjusted operating income were both down 21% from a year ago.

Texture & Healthful Solutions

Net Sales

$ in millions	2025	FX Impact	Volume	Price Mix	2026	Change	Change excl. FX
Third Quarter	605	(3)	12	(4)	610	1%	1%
Year-to-Date	1,806	15	69	(36)	1,854	3%	2%

Segment Operating Income

$ in millions	2025	FX Impact	Business Drivers	2026	Change	Change excl. FX
Third Quarter	105	(1)	(9)	95	(10%)	(9%)
Year-to-Date	315	3	(6)	312	(1%)	(2%)

Third quarter operating income for Texture & Healthful Solutions was $95 million, down $10 million from a year ago, driven by unfavorable tapioca costs and manufacturing expense, as well as unfavorable price mix, partially offset by positive volumes and operating expense. Excluding foreign exchange translation impacts, segment operating income was down 9%.

Food & Industrial Ingredients-LATAM

Net Sales

$ in millions	2025	FX Impact	Volume	Price Mix	2026	Change	Change excl. FX
Third Quarter	585	30	21	(12)	624	7%	2%
Year-to-Date	1,754	78	9	(27)	1,814	3%	(1%)

Segment Operating Income

$ in millions	2025	FX Impact	Business Drivers	Argentina JV	2026	Change	Change excl. FX
Third Quarter	116	5	(15)	3	109	(6%)	(10%)
Year-to-Date	370	11	(46)	7	342	(8%)	(11%)

Third quarter operating income for Food & Industrial Ingredients-LATAM was $109 million, a $7 million decrease from a year ago, driven primarily by Mexico's transactional currency impact and the business disruption resulting from the earthquake in Colombia, partially offset by higher volumes. Excluding foreign exchange translational impacts, segment operating income was down 10%.

Food & Industrial Ingredients?U.S./CAN

Net Sales

$ in millions	2025	FX Impact	Volume	Price Mix	2026	Change	Change excl. FX
Third Quarter	507	(1)	(15)	13	504	(1%)	-%
Year-to-Date	1,550	1	(75)	(9)	1,467	(5%)	(5%)

Segment Operating Income

$ in millions	2025	FX Impact	Business Drivers		2026	Change		Change excl. FX
Third Quarter	81	-	(29	)	52	(36	%)	(36	%)
Year-to-Date	259	1	(116	)	144	(44	%)	(44	%)

Third quarter operating income for Food & Industrial Ingredients?U.S./CAN was $52 million, a $29 million decrease from the prior year. The decline resulted from higher manufacturing expenses at our Argo facility, as well as volume declines, partially offset by favorable price mix. Excluding foreign exchange translation impacts, operating income was down 36%.

All Other**

Net Sales

$ in millions	2025	FX Impact	Volume	Pakistan Volume*	Price Mix	2026	Change	Change excl. FX
Third Quarter	119	-	3	(65)	(3)	54	(55%)	(55%)
Year-to-Date	352	1	6	(65)	5	299	(15%)	(15%)

*Represents loss of volume due to the sale of the majority stake in our Pakistan business

All Other Operating Loss

$ in millions	2025	FX Impact	Pakistan	Business Drivers	2026	Change	Change excl. FX
Third Quarter	(4)	-	(9)	2	(11)	NM	NM
Year-to-Date	(5)	-	(9)	12	(2)	NM	NM

Third quarter operating loss for All Other increased $7 million from the prior year, reflecting the impact of the sale of the majority stake in our Pakistan business partially offset by continued improvements in the Protein Fortification business.

** All Other consists of the businesses of multiple operating segments that are not individually or collectively classified as reportable segments. Net sales from All Other are generated primarily by sales of stevia and other ingredients from our PureCircle and other sugar reduction businesses, and pea protein ingredients from our Protein Fortification business.

Other Financial Items

At September 30, 2026, total debt was $1.8 billion, and cash, including short-term investments, was $993 million, versus $1.8 billion and $1.0 billion at December 31, 2025.

Net adjusted financing costs were $10 million in third quarter 2026, compared to $7 million in third quarter 2025.

Reported and adjusted effective tax rates for the third quarter were 26.8% and 26.4%, respectively, compared to 28.6% and 26.4%, respectively, for the year-ago period. The decrease in the reported effective tax rate was primarily driven by the change in the permanent reinvestment status of our Pakistan business recorded in the prior-year period and a favorable ruling in Brazil related to the taxability of ICMS credits. These favorable impacts were partially offset by the change in the value of the Mexican peso relative to the U.S. dollar.

Capital expenditures totaled $313 million through September 30, 2026, partially offset by proceeds of $36 million from the sales of certain properties.

Dividends and Share Repurchases

In the third quarter, the Company paid $53 million in dividends to shareholders. On September 17, 2026, the Company declared a quarterly dividend increase to $0.83 per share, which was paid on October 20, 2026, marking the 12th consecutive year of dividend increases. Through September 30, the Company repurchased $85 million of common stock and is on track to complete its $100 million full-year share repurchase target.

Updated Full-Year 2026 Outlook

The Company now expects its full-year 2026 reported diluted EPS to be in the range of $8.04 to $8.49, and its adjusted diluted EPS to be in the range of $9.25 to $9.70.

The Company now expects full-year 2026 net sales to be flat, reflecting volume growth and favorable foreign exchange, offset by lower price mix as well as the impact of the previously mentioned sale of its majority stake in the Pakistan business. Excluding results of the Pakistan business, net sales is expected to be flat to up low single digits.

Reported operating income is expected to be down low double digits, with adjusted operating income now expected to be down mid-teens for full-year 2026, which reflects the operational challenges in F&II-U.S./CAN.

The 2026 full-year outlook further assumes the following: Texture & Healthful Solutions operating income is now expected to be flat to up low single-digits, driven by sales volume growth, offset by expected higher input cost inflation; Food & Industrial Ingredients-LATAM operating income is now anticipated to be down mid-to-high single-digits, reflecting the continued strength of the Mexican peso; Food & Industrial Ingredients-U.S./CAN operating income is now expected to be down 35-40%, driven by operating costs at Argo; and All Other's operating loss is still anticipated to be approximately $(15) million, which reflects the absence of a second half earnings contribution from the sale of the Pakistan business.

Corporate costs for full-year 2026 are expected to be down mid-single digits.

For full-year 2026, the Company expects a reported effective tax rate of 27.9% to 28.9% and expects an adjusted effective tax rate of 26.5% to 27.5%.

Cash from operations for the full year 2026 is now expected to be in the range of $650 million to $750 million. Capital expenditures for the full year are still expected to be approximately $450 to $490 million.

This guidance reflects tariff levels in effect as of the end of October 2026. In addition, this guidance excludes acquisition-related integration and restructuring costs, as well as any potential impairment costs.

Conference Call and Webcast Details

Ingredion will host a conference call on Thursday, November 5, 2026, at 8 a.m. CT/9 a.m. ET, hosted by Jim Zallie, chairman, president and chief executive officer and Diego Reynoso, executive vice president and chief financial officer. The call will be webcast in real time and can be accessed at https://ir.ingredionincorporated.com/events-and-presentations. A presentation containing additional financial and operating information will be accessible through the Company's website and available to download a few hours before the start of the call. A replay will be available for a limited time at https://ir.ingredionincorporated.com/financial-information/quarterly-results.

About Ingredion

Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2025 annual net sales of approximately $7.2 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion Idea Labs? innovation centers located around the world and more than 11,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.

Forward-Looking Statements

This news release contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Ingredion Incorporated intends these forward-looking statements to be covered by the safe harbor provisions for such statements.

Forward-looking statements include, among others, any statements regarding our expectations for full-year 2026 reported and adjusted diluted earnings per share, net sales, reported and adjusted operating income, segment operating income, corporate costs, reported and adjusted effective tax rate, cash from operations, and capital expenditures, and any other statements regarding our prospects and our future operations, financial condition, volumes, cash flows, expenses or other financial items, including management's plans or strategies and objectives for any of the foregoing and any assumptions, expectations, or beliefs underlying any of the foregoing. In addition, such statements include statements regarding our expectations with respect to completion and benefits of the pending acquisition of Tate & Lyle (the "pending acquisition"), including statements regarding plans, objectives, intentions and expectations with respect to the future operations and financial performance of the combined group.

These statements can sometimes be identified by the use of forward-looking words such as "may," "will," "should," "anticipate," "assume," "believe," "plan," "project," "estimate," "expect," "intend," "continue," "pro forma," "forecast," "outlook," "opportunities," "potential," or other similar expressions or the negative thereof. All statements other than statements of historical facts therein are "forward-looking statements."

These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and beyond our control. Although we believe our expectations reflected in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.

The following factors relating to the pending acquisition, among others, could cause actual results to differ materially from those expressed in or implied by our forward-looking statements with respect to other matters: failure of the pending acquisition to be completed when expected or at all because of the inability to satisfy material antitrust or other conditions or for other reasons; the risk that the expected benefits of the pending acquisition may not be fully realized or may take longer to realize than anticipated, including as a result of the risks and uncertainties discussed below; failure to integrate effectively the businesses of Ingredion and Tate & Lyle or to manage effectively the expanded operations of the combined group; the incurrence of substantial expenses and indebtedness by Ingredion and the combined group to complete the pending acquisition and to operate the enterprise after completion; and the risk of loss of contracts and customers, distributors, suppliers, vendors and other business partners of Tate & Lyle as a results of the pending acquisition.

Actual results and developments may differ materially from the expectations expressed in or implied by our forward-looking statements, based on various risks and uncertainties, including changes in consumer practices, preferences, price sensitivity, behaviors, demand and perceptions; the impact of geopolitical developments, tensions, threats or conflicts on the availability and prices of raw materials and energy supplies, supply chains and foreign exchange and interest rates; the impact of global business and economic conditions on demand for our products or our access to global credit and equity markets; our reliance on certain industries for a significant portion of our sales; operating difficulties at our manufacturing facilities and liabilities relating to product safety and quality; our ability to keep pace with technological developments in research and development and continue to offer innovative products; competitive pressures that may adversely affect our market share, revenue and profitability; market volatility that may adversely affect our ability to pass through potential increases in the cost of corn and other raw materials to customers, to purchase quantities of corn and other raw materials at prices sufficient to sustain or increase our profitability, or to supply product quantities and meet shipment delivery requirements that our customers demand; the impact on inputs to our procurement, production processes and delivery channels, such as raw material, energy, and freight and logistics, of price fluctuations, supply chain interruptions, tariffs, duties, and shortages; our ability to contain costs, manage working capital, and achieve budgets, including completion of planned maintenance and investment projects on time and on budget; global climate change and legal, regulatory, or market measures to address climate change; our ability to identify and complete acquisitions, divestitures, or strategic alliances on favorable terms or achieve anticipated synergies; the economic, political and other risks inherent in conducting operations in foreign countries and with foreign currencies; our ability to maintain satisfactory labor relations; our ability to attract, develop, retain, motivate and maintain good relationships with our workforce, including key personnel; the impact of legal and regulatory proceedings; the risks associated with pandemics; the impact of any impairment charges on intangible assets and goodwill; global and regional economic policies and changes to existing laws and regulations; changes in our tax rates or exposure to additional income tax liabilities; increases in interest rates that could increase our borrowing costs; risks affecting our ability to raise funds at reasonable rates and other factors affecting our access to sufficient funds for future growth and expansion; risks relating to the use of artificial intelligence and other advanced technologies, and our reliance on third‑party technology providers; interruptions, security incidents, or failures with respect to information technology systems, processes, and sites; risks affecting the continuation of our dividend policy; and our ability to maintain effective internal control over financial reporting.

Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments or otherwise. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see "Risk Factors" and other information included in our Annual Report on Form 10-K for the year ended December 31, 2025, and in our subsequent reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission.

Additional Information

This press release is for information purposes and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the all-cash offer by the Company for the entire issued and to be issued ordinary share capital of Tate & Lyle, or otherwise, nor shall there be any sale, issuance or transfer of securities of Tate & Lyle in any jurisdiction in contravention of applicable law. The pending acquisition will be made solely by means of a scheme of arrangement (or, if the pending acquisition is implemented by way of a takeover offer, as that term is defined in the UK Companies Act 2006 (a "Takeover Offer"), the offer document), which will contain the full terms and conditions of the pending acquisition. If the Company exercises its right to implement the pending acquisition by way of a Takeover Offer, such offer will be made in compliance with applicable U.S. laws and regulations.

CONTACTS:

Investors: Noah Weiss, 773-896-5242

Media: Rick Wion, 708-209-6323

Ingredion Incorporated Condensed Consolidated Statements of Income (Unaudited) (dollars and shares in millions, except per share data)

	Three Months Ended September 30,					Change %	Nine Months Ended September 30,						Change %
		2026		2025		Change %		2026			2025		Change %
Net sales	$	1,792		$	1,816	(1%)	$	5,434		$	5,462		(1%)
Cost of sales		1,393			1,361			4,208			4,064
Gross profit		399			455	(12%)		1,226			1,398		(12%)
Operating expenses		215			203	6%		622			604		3%
Other operating (income), net		(3	)		-			(30	)		(15	)
Restructuring/impairment charges, net		(14	)		3			42			13
Operating income		201			249	(19%)		592			796		(26%)
Financing costs		5			7			69			28
Net (gain) on sale of business		-			-			(44	)		-
Other non-operating expense, net		2			1			4			1
Income before income taxes		194			241	(20%)		563			767		(27%)
Provision for income taxes		52			69			161			198
Net income		142			172	(17%)		402			569		(29%)
Less: Net income attributable to non-controlling interests		-			1			4			5
Net income attributable to Ingredion	$	142		$	171	(17%)	$	398		$	564		(29%)

Earnings per common share attributable to Ingredion common shareholders:

Weighted average common shares outstanding:
Basic		63.1			64.3			63.2			64.4
Diluted		63.7			65.4			63.8			65.5

Earnings per common share of Ingredion:
Basic	$	2.25		$	2.66	(15%)	$	6.30		$	8.76		(28%)
Diluted	$	2.23		$	2.61	(15%)	$	6.24		$	8.61		(28%)

Ingredion Incorporated Condensed Consolidated Balance Sheets (dollars and shares in millions, except per share amounts)

	September 30, 2026			December 31, 2025
	(Unaudited)			December 31, 2025
Assets
Current assets:
Cash and cash equivalents	$	989		$	1,030
Short-term investments		4			3
Accounts receivable, net		1,346			1,185
Inventories		1,151			1,227
Prepaid expenses and assets held for sale		70			60
Total current assets		3,560			3,505
Property, plant and equipment, net		2,560			2,526
Goodwill		917			922
Intangible assets, net		330			347
Other non-current assets		760			597
Total assets	$	8,127		$	7,897

Liabilities and stockholders' equity
Current liabilities:
Short-term borrowings	$	533		$	48
Accounts payable, accrued liabilities and liabilities held for sale		1,241			1,268
Total current liabilities		1,774			1,316
Long-term debt		1,242			1,742
Other non-current liabilities		502			473
Total liabilities		3,518			3,531

Share-based payments subject to redemption		56			64
Redeemable non-controlling interests		-	-		7

Ingredion stockholders' equity:
Preferred stock ? authorized 25.0 shares ? $0.01 par value, none issued		-			-
Common stock ? authorized 200.0 shares ? $0.01 par value, 77.8 shares issued at September 30, 2026 and December 31, 2025		1			1
Additional paid-in capital		1,147			1,155
Less: Treasury stock (common stock: 15.4 and 14.8 shares at September 30, 2026 and December 31, 2025) at cost		(1,624	)		(1,555	)
Accumulated other comprehensive loss		(822	)		(937	)
Retained earnings		5,851			5,610
Total Ingredion stockholders' equity		4,553			4,274
Non-redeemable non-controlling interests		-			21
Total stockholders' equity		4,553			4,295
Total liabilities and stockholders' equity	$	8,127		$	7,897

Ingredion Incorporated Condensed Consolidated Statements of Cash Flows (Unaudited) (dollars in millions)

	Nine Months Ended September 30,
		2026			2025
Cash from operating activities
Net income	$	402		$	569
Non-cash charges to net income:
Depreciation and amortization		165			165
Mechanical stores expense		56			50
Net (gain) on sale of business		(44	)		-
(Gain) on sale of land		(26	)		-
Impairment charges		39			6
Foreign exchange losses, net		44			3
Deferred income taxes		6			2
Margin accounts		17			3
Changes in other working capital		(219	)		(235	)
Other		(51	)		(24	)
Cash provided by operating activities		389			539
Cash from investing activities
Capital expenditures and mechanical stores purchases		(313	)		(299	)
Proceeds from disposal of manufacturing facilities and equipment		36			1
Proceeds from sales of businesses, net		139			12
Purchases of equity securities, net		(26	)		(11	)
Other		(5	)		(5	)
Cash used for investing activities		(169	)		(302	)
Cash from financing activities
Proceeds (payments) on borrowings, net		29			(37	)
Repurchases of common stock, net		(85	)		(134	)
Common stock activity for share-based compensation, net		(10	)		(12	)
Purchases of non-controlling interests		(34	)		-
Dividends paid, including to non-controlling interests		(158	)		(157	)
Cash used for financing activities		(258	)		(340	)
Effects of foreign exchange rate changes on cash and cash equivalents		(3	)		21
(Decrease) in cash and cash equivalents		(41	)		(82	)
Cash and cash equivalents, beginning of period		1,030			997
Cash and cash equivalents, end of period	$	989		$	915

Ingredion Incorporated
Supplemental Financial Information
(Unaudited)
(dollars in millions, except for percentages)

I. Segment Information of Net Sales to Unaffiliated Customers and Operating Income

	Three Months Ended September 30,						Change %	Change Excl. FX %	Nine Months Ended September 30,						Change %	Change Excl. FX %
		2026			2025		Change %	Change Excl. FX %		2026			2025		Change %	Change Excl. FX %
Net Sales to Unaffiliated Customers:
Texture & Healthful Solutions (i)	$	610		$	605		1%	1%	$	1,854		$	1,806		3%	2%
Food & Industrial Ingredients?LATAM (ii)		624			585		7%	2%		1,814			1,754		3%	(1%)
Food & Industrial Ingredients?U.S./Canada (iii)		504			507		(1%)	-%		1,467			1,550		(5%)	(5%)
All Other (iv)		54			119		(55%)	(55%)		299			352		(15%)	(15%)
Net Sales	$	1,792		$	1,816		(1%)	(3%)	$	5,434		$	5,462		(1%)	(2%)

Operating Income (Loss):
Texture & Healthful Solutions	$	95		$	105		(10%)	(9%)	$	312		$	315		(1%)	(2%)
Food & Industrial Ingredients?LATAM		109			116		(6%)	(10%)		342			370		(8%)	(11%)
Food & Industrial Ingredients?U.S./Canada		52			81		(36%)	(36%)		144			259		(44%)	(44%)
All Other		(11	)		(4	)	NM	NM		(2	)		(5	)	NM	NM
Corporate		(39	)		(44	)	(11%)	(11%)		(120	)		(139	)	(14%)	(14%)
Adjusted Operating Income		206			254		(19%)	(21%)		676			800		(16%)	(18%)
Acquisition/integration costs, net		(11	)		-					(17	)		-
Impairment charges		(3	)		-					(34	)		(6	)
Restructuring costs, net		17			(3	)				(8	)		(7	)
Other matters		(8	)		(2	)				(25	)		9
Operating Income	$	201		$	249		(19%)	(21%)	$	592		$	796		(26%)	(28%)

Notes to Net Sales to Unaffiliated Customers

(i) Net of inter-segment sales of $22 million and $7 million for the third quarter of 2026 and 2025, and $66 million and $25 million for year-to-date 2026 and 2025.

(ii) Net of inter-segment sales of $17 million and $12 million for the third quarter of 2026 and 2025, and $38 million and $39 million for year-to-date 2026 and 2025.

(iii) Net of inter-segment sales of $37 million and $25 million for the third quarter of 2026 and 2025, and $112 million and $85 million for year-to-date 2026 and 2025.

(iv) Net of inter-segment sales of $6 million and $3 million for the third quarter of 2026 and 2025, and $18 million and $10 million for year-to-date 2026 and 2025.

II. Non-GAAP Information

To supplement the consolidated financial results prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), non-GAAP historical financial measures are used, which exclude certain GAAP items such as acquisition/integration costs, restructuring costs, impairment charges, net (gain) on sale of business, Mexico tax item, and other specified items. The term "adjusted" is generally used when referring to these non-GAAP financial measures.

Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a more meaningful, consistent comparison of the Company's operating results and trends for the periods presented. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business. Expected financial measures may not reflect certain future charges, costs and/or gains that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance. Non-GAAP adjustments are generally made to adjusted financial measures, which increases management's confidence in its ability to forecast adjusted financial measures than in its ability to forecast GAAP financial measures. These non-GAAP measures, including non-GAAP expected measures, should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.

Non-GAAP financial measures are not prepared in accordance with GAAP; therefore, the Company's non-GAAP information is not necessarily comparable to similarly titled measures presented by other companies. A reconciliation of each non-GAAP financial measure to the most comparable GAAP measure is provided in the tables below.

Ingredion Incorporated Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS (Unaudited)

	Three Months Ended September 30, 2026						Nine Months Ended September 30, 2026
	(in millions)			Diluted EPS			(in millions)			Diluted EPS
Net income attributable to Ingredion	$	142		$	2.23		$	398		$	6.24

Adjustments:

Acquisition/integration costs, net (i)		6			0.09			47			0.74

Impairment charges (ii)		5			0.08			27			0.42

Restructuring costs, net (iii)		(12	)		(0.18	)		7			0.11

Net (gain) on sale of business (iv)		-			-			(17	)		(0.27	)

Other matters (v)		6			0.09			18			0.29

Tax item?Mexico (vi)		3			0.05			(3	)		(0.05	)

Other tax matters (vii)		(5	)		(0.08	)		(2	)		(0.03	)

Non-GAAP adjusted net income attributable to Ingredion	$	145		$	2.28		$	475		$	7.45

	Three Months Ended September 30, 2025						Nine Months Ended September 30, 2025
	(in millions)			Diluted EPS			(in millions)			Diluted EPS
Net income attributable to Ingredion	$	171		$	2.61		$	564		$	8.61

Adjustments:

Impairment charges (ii)		-			-			4			0.06

Restructuring costs, net (iii)		3			0.05			6			0.09

Other matters (v)		1			0.02			(7	)		(0.10	)

Tax item?Mexico (vi)		(3	)		(0.05	)		(10	)		(0.15	)

Other tax matters (vii)		8			0.12			6			0.09

Non-GAAP adjusted net income attributable to Ingredion	$	180		$	2.75		$	563		$	8.60

Net income and EPS may not sum or recalculate due to rounding.

Notes

(i) During the three and nine months ended September 30, 2026, we recorded net pre-tax acquisition and integration costs of $6 million and $59 million primarily related to our pending acquisition of Tate & Lyle, including $5 million and $42 million of gains and losses of acquisition-related foreign exchange hedging for the three and nine months ended September 30, 2026. There was no such activity during the three and nine months ended September 30, 2025.

(ii) During the three and nine months ended September 30, 2026, we recorded pre-tax impairment charges of $6 million and $39 million. In the third quarter we recorded a charge related to the sale of our facility in Vanscoy, Canada and impairment charge on an equity investment. In addition, we recorded charges relating to the closure our Cabo, Brazil facility in the first half of 2026. During the nine months ended September 30, 2025, we recorded $6 million of pre-tax impairment charges on our equity investments.

(iii) During the three and nine months ended September 30, 2026, we recorded a pre-tax restructuring benefit of $17 million and pre-tax restructuring charges of $8 million. The benefit during the quarter was primarily from the gain on the sale of land in Lane Cove, Australia. During the nine months ended September 30, 2026, the gain on sale of land was fully offset by restructuring costs primarily related to the closure of our facility in Cabo, Brazil and the sale of our Pakistan business. During the three and nine months ended September 30, 2025, we recorded pre-tax restructuring costs of $3 million and $7 million, primarily related to decommissioning costs for plant closures.

(iv) During the nine months ended September 30, 2026, we recorded a net pre-tax gain of $44 million related to the sale of our Pakistan business. There was no such activity during September 30, 2025.

(v) During the three and nine months ended September 30, 2026, we recorded pre-tax charges of $8 million and $25 million primarily related to the Argo thermal event. During the three and nine months ended September 30, 2025, we recorded pre-tax expenses of $2 million and pre-tax benefits of $9 million primarily related to insurance recoveries and a favorable judgment related to certain indirect taxes.

(vi) The tax amounts are result of the movement of the Mexican peso against the U.S. dollar and its impact on the remeasurement of the Mexico financial statements during the period.

(vii) During the three and nine months ended September 30, 2026, we recognized tax benefits, including interest income associated with certain Brazilian local incentives and the recognition of a U.S. deferred tax asset. These benefits were partially offset by the related tax impacts of current- and prior-year non-GAAP adjustments and the recapture of prior-year U.S. tax benefits. Additionally, during the nine months ended September 30, 2026, we recognized tax benefits associated with the utilization of previously unbenefited capital losses. These benefits were partially offset by changes in our accrual related to the permanent reinvestment of foreign earnings and the recognition of prior-year tax liabilities.

Ingredion Incorporated Reconciliation of GAAP Operating Income to Non-GAAP Adjusted Operating Income (Unaudited) (dollars in millions, pre-tax)

	Three Months Ended September 30,					Nine Months Ended September 30,
		2026			2025		2026		2025
Operating income	$	201		$	249	$	592	$	796

Adjustments:

Acquisition/integration costs, net (i)		11			-		17		-

Impairment charges (ii)		3			-		34		6

Restructuring costs, net (iii)		(17	)		3		8		7

Other matters (v)		8			2		25		(9	)

Non-GAAP adjusted operating income	$	206		$	254	$	676	$	800

For notes (i) through (v), see notes (i) through (v) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Ingredion Incorporated Reconciliation of GAAP Financing Costs to Non-GAAP Adjusted Financing Costs (Unaudited) (dollars in millions, pre-tax)

	Three Months Ended September 30,				Nine Months Ended September 30,
		2026		2025		2026			2025
Financing costs	$	5	$	7	$	69		$	28

Adjustments:

Acquisition/integration costs, net (i)		5		-		(42	)		-

Non-GAAP adjusted financing costs	$	10	$	7	$	27		$	28

For note (i), see note (i) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Ingredion Incorporated Reconciliation of GAAP Effective Income Tax Rate to Non-GAAP Adjusted Effective Income Tax Rate (Unaudited) (dollars in millions, except for percentages)

	Three Months Ended September 30, 2026							Nine Months Ended September 30, 2026
	Income before Income Taxes (a)			Provision for Income Taxes (b)			Effective Income Tax Rate (b/a)	Income before Income Taxes (a)			Provision for Income Taxes (b)			Effective Income Tax Rate (b/a)
As Reported	$	194		$	52		26.8%	$	563		$	161		28.6%

Adjustments:

Acquisition/integration costs, net (i)		6			-				59			12

Impairment charges (ii)		6			1				39			12

Restructuring costs, net (iii)		(17	)		(5	)			8			1

Net (gain) on sale of business (iv)		-			-				(44	)		(27	)

Other matters (v)		8			2				25			7

Tax item?Mexico (vi)		-			(3	)			-			3

Other tax matters (vii)		-			5				-			2

Adjusted Non-GAAP	$	197		$	52		26.4%	$	650		$	171		26.3%

	Three Months Ended September 30, 2025						Nine Months Ended September 30, 2025
	Income before Income Taxes (a)		Provision for Income Taxes (b)			Effective Income Tax Rate (b/a)	Income before Income Taxes (a)			Provision for Income Taxes (b)			Effective Income Tax Rate (b/a)
As Reported	$	241	$	69		28.6%	$	767		$	198		25.8%

Adjustments:

Impairment charges (ii)		-		-				6			2

Restructuring costs, net (iii)		3		-				7			1

Other matters (v)		2		1				(9	)		(2	)

Tax item?Mexico (vi)		-		3				-			10

Other tax matters (vii)		-		(8	)			-			(6	)

Adjusted Non-GAAP	$	246	$	65		26.4%	$	771		$	203		26.3%

For notes (i) through (vii), see notes (i) through (vii) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Ingredion Incorporated Reconciliation of Expected GAAP Diluted Earnings Per Share ("GAAP EPS") to Expected Adjusted Diluted Earnings Per Share ("Adjusted EPS") (Unaudited)

	Expected EPS Range for Full-Year 2026
	Low End of Guidance			High End of Guidance
GAAP EPS	$	8.04		$	8.49

Adjustments:

Acquisition/integration costs, net (i)		0.74			0.74

Impairment charges (ii)		0.42			0.42

Restructuring costs, net (iii)		0.11			0.11

Net (gain) on sale of business (iv)		(0.27	)		(0.27	)

Other matters (v)		0.29			0.29

Tax item-Mexico (vi)		(0.05	)		(0.05	)

Other tax matters (vii)		(0.03	)		(0.03	)

Adjusted EPS	$	9.25		$	9.70

or notes (i) through (vii), see notes (i) through (vii) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS.

Ingredion Incorporated
Reconciliation of Expected GAAP Effective Income Tax Rate ("GAAP ETR")
to Expected Adjusted Effective Income Tax Rate ("Adjusted ETR")
(Unaudited)

	Expected Effective Income Tax Rate Range for Full-Year 2026
	Low End of Guidance		High End of Guidance
GAAP ETR	27.9	%	28.9	%

Adjustments:

Acquisition/integration costs, net (i)	(0.4	%)	(0.4	%)

Impairment charges (ii)	0.1	%	0.1	%

Restructuring costs, net (iii)	(0.1	%)	(0.1	%)

Net (gain) on sale of business (iv)	(1.7	%)	(1.7	%)

Other matters (v)	0.1	%	0.1	%

Tax item?Mexico (vi)	0.3	%	0.3	%

Other tax matters (vii)	0.3	%	0.3	%

Adjusted ETR	26.5	%	27.5	%

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL - based medicines

Fri, 06 Nov 2026 18:55:00 +0700

Ghent, Belgium - November 5, 2026 , Nov. 05, 2026 (GLOBE NEWSWIRE) -- MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL-based medicines

Collaboration combines MRM Health's cutting-edge microbiome science and proprietary CORAL platform with Biocodex's industrialization and manufacturing capabilities

Planned EUR15 million investment by Biocodex in specialized anaerobic manufacturing infrastructure will establish an additional pathway for MH002 and other MRM Health programs, from clinical development toward potential commercial supply

The specialized manufacturing capacity strengthens MRM Health's readiness for pharmaceutical partnerships while preserving manufacturing flexibility and ownership of its platform and product-related innovations

MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, and Biocodex, an independent French pharmaceutical company with more than 70 years of experience in the microbiome field, today announced the launch of a strategic partnership to establish specialized manufacturing capabilities for live biotherapeutic products. The collaboration combines MRM Health's cutting-edge microbiome science and proprietary CORAL platform with Biocodex's pharmaceutical development, industrialization and manufacturing capabilities.

The partnership is designed to support both MRM Health's lead asset MH002 and other CORAL-based programs across the product lifecycle, from process development and clinical manufacturing toward potential future commercial supply. By establishing access to specialized manufacturing infrastructure alongside the clinical development of its pipeline, MRM Health is addressing an important future manufacturing and supply requirement for complex live biotherapeutic products and further strengthening the readiness of its programs for pharmaceutical partnerships and commercialization.

Biocodex will invest EUR15 million over the coming years in a new manufacturing infrastructure dedicated to live biotherapeutic products, including anaerobic manufacturing capabilities at its state-of-the-art pharmaceutical site in Beauvais, France. Biocodex will fund, build, own and operate the facility, while MRM Health will contribute its proprietary anaerobic manufacturing expertise to its design and implementation. The infrastructure will be designed to support the specific manufacturing requirements of products derived from MRM Health's proprietary CORAL platform, while also supporting other live biotherapeutic programs.

"Developing next-generation live biotherapeutics into successful medicines requires manufacturing capabilities that are just as sophisticated as the underlying science," said Dr. Sam Possemiers, Chief Executive Officer of MRM Health. "Together with Biocodex we are establishing a specialized and scalable manufacturing pathway from clinical development to future commercial production. This partnership strengthens the readiness of both our own pipeline and CORAL programs developed with pharmaceutical partners for future commercialization, bringing us closer to delivering microbiome-based therapeutics to patients."

"This strategic collaboration strengthens the partnership we began last year with MRM Health," added Nicolas Coudurier, Chief Executive Officer of Biocodex. "By combining our expertise, we are helping to strengthen European industrial capabilities in the field of live biotherapeutics. This is an important step in supporting the development of these new therapeutic approaches and ultimately enabling patients to benefit from them."

A platform-enabling partnership supporting multiple MRM programs

The partnership establishes a framework under which Biocodex may provide process development, analytical testing and GMP manufacturing services for individual CORAL programs under program-specific agreements. MRM Health will have access to the manufacturing infrastructure for its proprietary, partnered and out-licensed CORAL programs.

The non-exclusive nature of the collaboration preserves MRM Health's flexibility to engage additional or alternative manufacturing partners where appropriate. This flexible partnership provides an additional manufacturing pathway for its lead candidate MH002 and its broader pipeline while reducing the need for its pharmaceutical partners to establish specialized manufacturing pathways independently as programs advance toward commercialization.

Scalable industrial support, from development to commercial supply

MRM Health has developed proprietary expertise in the scalable manufacturing of complex bacterial consortia through its single-process CORAL production technology. The new infrastructure will build on this proficiency, as well as on the industrial experience of Biocodex, and provide a coordinated pathway for technology transfer, process development, clinical manufacturing and future commercial supply.

The facility will provide flexible manufacturing infrastructure across multiple scales. For MRM Health, it will enable the progression of both MH002 and other pipeline programs from development through later-stage clinical manufacturing and ultimately toward commercial-scale production. Capacity supporting CORAL programs will expand in line with the clinical and commercial progress of MRM Health's portfolio. Initial process development and pilot manufacturing activities are expected to begin by 2027, with commercial-scale manufacturing targeted from 2030.

About MRM Health

MRM Health is a clinical-stage biotech developing innovative live biotherapeutic products (LBPs) for immune-mediated diseases with high unmet needs. The Company's lead program, MH002, for inflammatory bowel diseases (IBD), is currently being evaluated in the 204-patient STARFISH-UC Phase 2b study in patients with mild-to-moderate ulcerative colitis, following positive Phase 2a clinical data in ulcerative colitis and pouchitis.

MH002 received FDA Fast Track designation in April 2026. MRM Health is expanding its pipeline across other inflammatory diseases and immuno-oncology, leveraging AI-guided discovery and deep expertise in microbiome ecosystem biology. Its CORAL platform enables the rational design and manufacture of disease-focused microbial consortia with enhanced efficacy and scalability. In September 2025, MRM Health successfully closed a EUR55 million Series B round led by Biocodex, with strong support from ATHOS, BNP Paribas Fortis Private Equity and existing investors SFPIM, AvH, OMX Europe VF, QBIC II and VIB.

About Biocodex

Biocodex is an independent French pharmaceutical company operating in more than 100 countries through its subsidiaries or partners. As a pioneer in gut microbiota research, the company has made it a central strategic focus, driven by the conviction that this ecosystem plays a key role in overall health and a more holistic approach to care.

The Group develops innovative healthcare solutions across four complementary areas: microbiota, women's health, rare diseases, and established products addressing everyday health needs (mental health, sleep, pain, etc.). True to its family-owned identity, Biocodex promotes a committed vision of health that combines scientific excellence, a strong industrial base in France, international reach, and corporate social responsibility. This commitment has been recognized with the "Engag? RSE" label - Confirmed level (★★), awarded by AFNOR Certification and recognized across Europe through Responsibility Europe.

Empowering everyone to live fully is Biocodex's purpose, embodied by its 1,900 employees worldwide.

ArrayPatch Completes Oversubscribed EUR 3.2 Million Seed Financing to Advance Next-Generation Microneedle Therapeutics

Thu, 05 Nov 2026 18:07:00 +0700

CORK, Ireland, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ArrayPatch Ltd ("ArrayPatch"), a biotech company developing innovative microneedle-based therapeutics, today announced the successful completion of the second close of its seed financing round, securing an additional EUR 1.6 million, bringing the total raised to EUR 3.2 million.

The latest investment comes from impact-focused venture capital firm WakeUp Capital along with funds raised via Spark Venture Funding and Dr. Mark Ledwidge plus existing lead investor Lakeside Capital and DeepIE Ventures.

The proceeds from the seed financing will be used to accelerate the development of programs leveraging its proprietary DerMap dissolving microneedle patch platform towards first-in-human studies, with an initial focus on GLP-DerMap for the treatment of obesity and diabetes, and VIS-DerMap for the treatment of basal cell carcinoma. DerMap is the only microneedle patch delivery technology whereby the microneedles are made entirely from the medicine being delivered, thus requiring no polymer, allowing significantly higher drug loading capacity. The platform can be used to deliver both small molecules and peptides.

"The successful completion of our EUR 3.2 million seed round is an important milestone for ArrayPatch and provides the resources to accelerate the development of our pipeline," said Dr. Waleed Faisal, Founder and CEO of ArrayPatch. "Our primary focus is now GLP-DerMap, where we believe our technology has the potential to offer a new, patient-friendly approach to the delivery of GLP-1 medicines. We are also continuing to advance our programmes in skin cancer and nail fungal infection."

"We are delighted to co-lead this round as ArrayPatch is advancing a novel technology designed to address numerous patient and environmental challenges associated with medicines administered by traditional injections, setting the company on track to make a significant global human and environmental impact." said Andrew Parish, Partner at WakeUp Capital.

Additional investors in the EUR3.2 million seed round included Enterprise Ireland, The Boole Investment Syndicate and a number of private investors. Andrew Parish, Partner at WakeUp Capital, will join the ArrayPatch Board of Directors, alongside recently appointed Chair, Dr. Neil Thomas.

About ArrayPatch Ltd

ArrayPatch is a biotech company based in Cork, Ireland, developing next-generation microneedle-based therapeutics. Its DerMap platform harnesses polymer-free dissolving microneedles to deliver therapeutic agents directly in a painless and efficient manner. The company's lead program, GLP-DerMap, is designed to address the challenges associated with current GLP-1 agonist injections by delivering the medicine in a pain-free patch and is currently in pre-clinical development.

Additional applications under development are VIS-DerMap for the treatment of basal cell carcinoma and ITZ-DerMap for the treatment of onychomycosis (nail fungus). ArrayPatch was spun out from University College Cork and has secured significant non-dilutive funding and industry recognition to support its development strategy. For more information, please visit www.array-patch.com

CGTN: Dialog Wali Kota Global menegaskan kembali komitmen Tiongkok terhadap keterbukaan

Thu, 05 Nov 2026 18:03:00 +0700

Pelabuhan Ningbo-Zhoushan. /CMG

BEIJING, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Acara utama Dialog Wali Kota Global 2026 ? Ningbo resmi dibuka pada hari Selasa di kota pelabuhan Ningbo, dengan menghadirkan perwakilan dari 15 negara dan 20 kota internasional.

Dengan mengusung tema "Keterbukaan dan Konektivitas untuk Peluang Bersama", acara ini menghasilkan 14 kesepakatan kerja sama serta Konsensus Ningbo tentang Pembangunan Kooperatif. Hasil tersebut menegaskan peran kota sebagai penggerak perdagangan terbuka yang saling menguntungkan.

Proyek-proyek yang telah disepakati mencakup pertukaran antarkota kembar, perdagangan dan investasi, sains dan pendidikan, kebudayaan dan pariwisata. "Keterbukaan kota terhadap dunia bukan sekadar langkah satu arah untuk menjangkau dunia luar, melainkan juga proses integrasi dua arah ke dalam rantai industri dan inovasi global," ujar Wali Kota Ningbo, Shen Mingquan.

Sebagai salah satu kota pesisir pertama di Tiongkok yang membuka diri terhadap dunia luar, Ningbo menjalin hubungan ekonomi dan perdagangan dengan lebih dari 220 negara dan wilayah di seluruh dunia.

Integrasi global ini telah menunjukkan hasil yang signifikan. Pada tahun 2024, delegasi Ningbo mengunjungi otoritas Terusan Suez di Mesir, dan Dashun Fur, perusahaan yang berbasis di Ningbo, menginvestasikan $40 juta di Zona Ekonomi Terusan Suez. Kerja sama mereka pun berkembang dari sektor tekstil tradisional ke logistik modern. Produk seperti susu bubuk dari Selandia Baru dan kurma dari Maroko banyak diminati warga Ningbo. Sementara itu, Maladewa termasuk dalam 10 besar destinasi wisata luar negeri pilihan warga Ningbo.

Tiongkok tetap menjadi negara dengan perdagangan barang terbesar di dunia dan importir terbesar kedua, serta mitra dagang utama bagi lebih dari 150 negara dan wilayah. Data kepabeanan menunjukkan bahwa nilai perdagangan barang Tiongkok mencapai 45,47 triliun yuan ($6,51 triliun) pada tahun 2025, naik 3,8% dibandingkan tahun sebelumnya, dengan nilai ekspor tercatat sebesar 26,99 triliun yuan ($4,06 triliun) dan impor mencapai 18,48 triliun yuan ($2,78 triliun).

Perdagangan dengan negara-negara mitra dalam inisiatif Sabuk dan Jalan menyumbang 51,9% dari total perdagangan luar negeri Tiongkok. Angka-angka tersebut menegaskan satu kenyataan mendasar: pertumbuhan Tiongkok membutuhkan dunia, dan dunia juga membutuhkan Tiongkok untuk mewujudkan kemakmuran global.

Dialog di Ningbo berulang kali menyoroti pilihan antara "membangun tembok" dan "membangun jembatan." Dalam acara pada hari Selasa tersebut, Wali Kota Auckland, Wayne Brown, membagikan kisah tentang bagaimana sebuah kota gerbang di Pasifik Selatan mengubah jarak menjadi keterbukaan. Karimi Said, Wali Kota Errachidia, Maroko, menyebut pertanian oasis dan kurma sebagai penghubung ke pasar global.

Pertukaran budaya selama acara tersebut-termasuk dokumen pada lempeng tembaga dari Atol Laamu di Maladewa, artefak kumbang scarab dari Suez, dan permen Norman dari Saint-?tienne, Prancis-ditempatkan sejajar dengan kontrak komersial. Hal ini mencerminkan penekanan Konsensus tersebut pada hubungan antarmasyarakat.

Konsensus Ningbo menegaskan komitmen para peserta terhadap kerja sama industri yang lebih mendalam, perdagangan terbuka, dan pertukaran antarmasyarakat. Hal ini sejalan dengan semangat kebersamaan dalam membangun masa depan bersama bagi umat manusia, yang mendorong terciptanya dunia tempat kota-kota saling mendukung melalui rasa saling percaya dan kerja sama yang saling menguntungkan.

Dengan menghubungkan pelabuhan, rantai pasok, dan masyarakat-baik secara langsung maupun melalui platform digital-ke-20 kota tersebut menyampaikan pesan yang jelas: Keterbukaan dan konektivitas, bukan isolasi, tetap menjadi jalan paling pasti untuk meraih peluang bersama.

Asia Left Behind: Ten international companies have yet to report delivering on their cage-free egg pledges across the region

Thu, 05 Nov 2026 17:55:00 +0700

Source: Malayang Manok Philippines

Several report full or near-full cage-free egg sourcing in all or part of Europe or North America. Their own reports show far lower figures, or none, for Asia.

BANGKOK, THAILAND - Media OutReach Newswire - 5 November 2026 - In October, more than fifty animal advocates gathered in Bangkok to call on ten international companies to deliver their cage-free egg commitments across Asia. The ten are Aramark, Grupo Bimbo, IHG Hotels & Resorts, Inspire Brands, Kraft Heinz, Marriott International, Mondelēz International, Radisson Hotel Group, Sodexo and Unilever.

Each of the ten published a commitment to source only cage-free eggs worldwide by 2025. Based on their public reports as of early-November, none has yet confirmed meeting that commitment in Asia, and several have since extended timelines, limited the scope to certain regions, or set no new deadline.

The gap between the West and Asia shows in the companies' own reports. IHG reports that 99.2% of its US hotels were aligned with its cage-free egg commitment in 2025, compared with 0% in Greater China. Marriott reports that 90.84% of egg spend at its managed US properties was cage-free in 2025, compared with 59.13% at its managed properties in Greater China.

Unilever reports 100% cage-free eggs in Europe and North America, but its latest available figure for Asia and Oceania is 7%, for 2023. It has said it will end its commitment to reach 100% cage-free eggs globally. Kraft Heinz's animal welfare policy, issued in September 2026, commits to sourcing only cage-free eggs in North America and Europe.

For other regions, including Asia, it says it will "continue to monitor the availability and affordability of cage-free eggs". Both companies describe North America and Europe as their "biggest markets". Sodexo has extended its timeline up to 2035 for countries where cage-free supply chains are still developing.

Radisson Hotel Group's April 2026 status report says it will focus on implementation "rather than setting additional time-bound public targets where credible pathways are not yet clear", and Grupo Bimbo cites factors affecting "the operational feasibility of completing the transition within the original timeline".

The advocates acknowledge the challenges, and several animal welfare groups work directly with egg producers in the region to build cage-free supply. Other companies already show that progress is possible. Hilton's latest report lists 100% cage-free egg sourcing in the Philippines and more than 95% in Malaysia and Thailand, among its managed hotels in Asia Pacific. Accor's June 2026 report shows 91% of its hotels in South Korea, 88% in the Philippines and 80% in Thailand offering only cage-free eggs at the end of 2025.

The advocates call on the companies to honour their 2025 commitments in Asia without further delay, and to publish market-by-market progress together with the concrete steps being taken.

Animal advocacy groups across Asia, including Farmed Animal Compliance Thailand, the Malaysia Accountability Project, the Indonesia Network for Compassionate Animal Farming, Malayang Manok PH, Vietnam Animal Welfare Watch and Accountability Lens Asia, will continue to track each company's public reporting and progress, and will share updates as companies publish new figures for Asia.

Notes for editors: Company figures are taken from each company's own published reports and policies, as checked on Nov 5, 2026. Some companies' goals excluded specific countries or types of egg; details are in the source table that follows this release.

Source table

Every figure comes from the company's own document unless marked "news". Shell and liquid eggs are shown separately where the company splits them. Sources checked on [date checked].

Company	2025 commitment	West, latest	Asia, latest	Change since	Sources
Aramark	Worldwide by 2025, shell and liquid (March 2017); covers "controlled spend", excludes ingredient eggs	Europe 83%, US 77% of eggs (2025)	No Asia figure; Asia and Latin America are under 15% of egg purchases	September 2026 update gives no date; April 2026 version mentioned "enriched cages and credits"	Sept 2026 update, April 2026 version, p.3, 2017 release, policy
Grupo Bimbo	100% cage-free supply by 2025 from suppliers "around the world" (December 2015)	North America 46% (2025)	Only a combined "Europe, Asia & Africa" figure: 57% (2025)	Cites "the operational feasibility of completing the transition within the original timeline"; no new date	December 2025 Cage Free Egg Report, 2015 release
IHG Hotels & Resorts	Goal: only cage-free "across our entire global estate by 2025" (December 2016)	US 99.2%, Europe 79.9% of hotels aligned (2025)	EAPAC 8.9%, Greater China 0% of hotels aligned (2025)	2025 reporting gives no target date. "Aligned" includes hotels in regulated markets and hotels that serve no eggs	2025 ESG Databook, p.12, 2016 release
Inspire Brands	"each brand that currently serves eggs has committed globally to 100% sourcing of cage-free eggs by 2025" (Good Citizens Report, 2022 edition)	Dunkin' US: approximately 30% of eggs on breakfast sandwiches (2022 report). Arby's met its commitment in 2020, with a footnote that supply shortages have limited availability	None published	Current website no longer states the global goal; it says Arby's met its commitment and SONIC and Dunkin' "continue to make positive progress"	Good Citizens Report 2022, PDF pp.28, 71, Inspire Food page
Kraft Heinz	Eggs globally from cage-free or better hens by 2025 (December 2017)	North America 66% (2024)	Asia Pacific 15% (2024)	Policy issued 16 September 2026: only cage-free eggs (directly sourced) in North America and Europe, "our biggest markets" (US, Canada, France, Italy, the Netherlands, Spain and the UK); no deadline. Outside these regions it "will continue to monitor the availability and affordability of cage-free eggs"	Global Animal Welfare Policy v2.0, ?3.7, 2025 ESG Report, p.12
Marriott International	All owned, managed and franchised hotels globally by end-2025; shell, liquid and egg products	US managed properties 90.84% of egg spend (2025)	Managed egg spend: APAC excl. China 74.91%, Greater China 59.13% (2025). Managed properties in Bhutan and Nepal at 100%	Report states no change. The 70.03% global figure covers managed and franchised hotels, so it isn't comparable with the regional figures	2026 Serve 360 Report, pp.8?9, 2022 statement
Mondelēz International	2016: US and Canada by 2020, Europe by 2025; later global by 2025 excluding Russia and Ukraine	US and Canada 100% by end-2020	No Asia figure found; China and Vietnam excluded from the 2027 goal	Now 2027, excluding China, Morocco, Russia, Ukraine and Vietnam; 82% in 2025 on that basis	Cage-free position, Goals & Progress, 2022 report, p.10
Radisson Hotel Group	Globally by 2025, shell, liquid and egg products (November 2019)	Europe 79% of reporting hotels (2025)	South Asia 47%, Southeast Asia Pacific 71%, China 45% of reporting hotels (2025; China excludes franchised). Only 11 of 18 China hotels reported	April 2026 status report sets no new date: no "additional time-bound public targets where credible pathways are not yet clear". Global: 72% of reporting hotels, 40% of all hotels	April 2026 status report, February 2026 update, 2019 release
Sodexo	Worldwide by 2025, shell and liquid (July 2016)	FY2025: 100% shell and liquid in 13 European countries; UK 98%; US shell 77%, liquid 89%	FY2025 shell eggs: China 0.4%, India 2.6%, Malaysia 0.6%, Philippines 0%, Singapore 1.5%, Thailand 3.8%; liquid 0% or not reported	2025 goal now described as covering countries making up 88% of revenue; 15 markets, including China, Hong Kong, India, Malaysia, the Philippines, Singapore and Thailand, moved to roadmaps ending 2030 or 2035	FY2025 Animal Welfare Performance Report, pp.3, 6?8, FY2024 report, p.4, URD FY2025, p.150
Unilever	"100% global 2025 target" (2018)	100% in Europe and North America; 68% globally (end-2024)	Asia and Oceania 7% (2023 actual, in the 2024 report); the 2025 Annual Report gives no cage-free egg figures	Says it "will end our commitment to reach 100% cage free eggs globally" and will "maintain 100% cage-free eggs in North America and Europe, which are our biggest markets" (page undated; news dates the change to late 2025)	Position page, 2024 report, 2025 Annual Report, Food Manufacture (news)

Companies credited in the release

Company	West, latest	Asia, latest	Cited in the release for	Source
Hilton	Americas 93%, EMEA 96% (managed)	APAC 42% (managed); Philippines 100%, Malaysia and Thailand over 95% (managed)	Country results in the Philippines, Malaysia and Thailand	2025 Responsible Sourcing Goals, p.5
Accor	Europe 80% of all hotels (end-2025)	Asia Pacific 73%, South Korea 91%, Philippines 88%, Thailand 80%, Greater China 17% of all hotels (end-2025, self-reported)	Country results in South Korea, the Philippines and Thailand	June 2026 progress report

The issuer is solely responsible for the content of this announcement.

Hashtags: #CageFree

Wood Mackenzie: One in five refineries at closure risk as global oil demand peaks in 2032

Thu, 05 Nov 2026 17:50:00 +0700

LONDON/HOUSTON/SINGAPORE, Nov. 05, 2026 (GLOBE NEWSWIRE) --

FOR IMMEDIATE RELEASE

Wood Mackenzie | www.woodmac.com

An estimated one in five of the world's oil refineries faces increasing risk of closure as global oil demand peaks and enters structural decline within the next decade, according to new research published today by Wood Mackenzie. For the refining industry, the firm says, hope is not a strategy.

Global refined product demand stands at 105 million barrels per day. Wood Mackenzie forecasts a rise to 108 mb/d by 2032, after which decline sets in. Roughly 20% of existing global capacity sits on what the report terms a "downward escalator," facing falling or negative operating net cash margins and increasing risk of closure. Demand peaks in 2032, but with 2040 only three to four refinery turnaround cycles away, the window for major investment decisions is closing. Despite this, some refinery investments will continue in locations such as India, driven by domestic demand growth and energy self-reliance policy, though it remains capacity added locally into a global market in structural decline.

"The sector has navigated structural change before, from the oil shocks of the 1970s to the investment capacity wave across the Middle East and Asia in the 2000s," said Alan Gelder, SVP Refining, Chemicals and Oil Markets, Wood Mackenzie. "The current pressure is different in kind, not just degree. For the first time, the industry faces sustained decline in end-market demand rather than a temporary supply disruption. Scale, complexity and location determine which assets have genuine options. For those without structural advantages, the absence of a credible adaptation plan is not a deferral. It is a decision."

The demand decline is not uniform

Gasoline faces the sharpest pressure from electric vehicle adoption. Diesel, gasoil and jet fuel are more resilient, as heavy road transport and aviation have no clear decarbonisation pathway. LPG and naphtha benefit from petrochemical feedstock demand, while specialty products including lubricants, bitumen and waxes are largely insulated, as bio-based alternatives do not yet exist at scale.

The current elevated refining margins, driven by the Middle East conflict and damage to Russian refineries, will return to more modest levels when the conflict ends. Refining margins are determined by crack spreads, not the oil price, and long-run average benchmark margins are slim. The sector generates lower returns on capital than upstream operations, making the investment required for adaptation harder to access when the need is greatest.

Five archetypes, sharply uneven exposure

Large-scale, high-complexity refineries, including major assets on the US Gulf Coast, modern export-oriented facilities in the Middle East and the Dangote refinery in Nigeria, are the most competitive. Complex chemical-integrated sites, increasingly common in China and parts of Europe and Asia, can redirect output from declining transport fuels into petrochemicals. These two archetypes have the broadest adaptation options and are best placed to become the integrated energy parks that define the sector's future.

Coastal cracking refineries, the most common OECD configuration, face direct international competition and narrower options. European assets face the most acute regional pressure. Small-scale specialty assets, focused on lubricants, bitumen and waxes, carry limited exposure to transport fuel decline. Small-scale, low-complexity refineries, many of them NOC-owned in developing countries, survive only through subsidies.

Many pathways exist, but not all are equally available

Wood Mackenzie identifies several adaptation strategies, though high capital costs and market uncertainty make many difficult to execute. Petrochemical integration is the primary route for large, complex sites, redirecting LPG and naphtha into olefins, aromatics and polymers; Asian and Middle Eastern operators, backed by state capital, lead here. Bio and circular conversion, producing renewable diesel and sustainable aviation fuel from used cooking oil and recycled plastics, suits EU coastal refineries. Conventional upgrading is most viable for Middle Eastern and Asian refiners with capital, land and export access. Carbon capture and storage is relevant primarily to European and OECD operators. For mid-tier assets, the options are capacity consolidation, a pivot to specialty products, full value-chain integration or diversification into tangential sectors such as power, LNG and ammonia.

"The capital required for the most of these adaptation strategies is substantial, and the sector's return profile makes raising it harder than it appears from the outside," said Chris Barry, Vice President, Downstream Consulting, Wood Mackenzie. "The risk is a mismatch between ambition and balance sheet capacity. Petrochemical and renewable fuels integration may be an attractive growth or diversification opportunity for large, complex, well-positioned assets. For structurally weaker sites, consolidating around local market strength or moving into specialty products is the more defensible route to long-term viability."

A bifurcated future

Oil products remain central to the global economy for several more decades, and well-positioned refineries have a viable future. The sector's long-term shape is bifurcated: world-class integrated energy and molecule parks producing fuels, petrochemicals and speciality products at one end; terminal conversion, repurposing or closure at the other. Sector specialists will survive by monetising local advantages in feedstock access, regulatory environment or state support. For investors and asset owners, the question is not whether a refinery will face pressure, but whether its archetype, location and ownership structure give it the tools to adapt.

Key details:

Refined product demand: 105 mb/d in 2025, peaking at 108 mb/d in 2032, then declining

Estimated 20% of existing global refining capacity at increasing risk of closure

More than 700 refineries worldwide

India: 40% of global refining capacity additions to 2030

Sustainable aviation fuels: up to 80% emissions reduction versus conventional jet fuel

Refinery complexity scored on a scale of 1 to 25; higher scores generally correlate with higher net cash margin

2040 is three to four refinery turnaround cycles away

Background

Wood Mackenzie's Horizons series draws on proprietary data from the firm's Refinery Evaluation Model and Product Markets Service. Net cash margin is defined as cash from refining operations after payment of feedstock, fixed and variable operating costs on a per-barrel-of-throughput basis. All demand forecasts and capacity risk estimates reflect Wood Mackenzie's analytical view as of the date of publication.

You have received this news release from Wood Mackenzie because of the details we hold about you. If the information we have is incorrect you can either provide your updated preferences by contacting our media relations team. If you do not wish to receive this type of email in the future, please reply with 'unsubscribe' in the subject header.  

About Wood Mackenzie:

Wood Mackenzie is the global leader in analytics, insights and proprietary data across the entire energy and natural resources landscape. For over 50 years our work has guided the decisions of the world's most influential energy producers, utilities companies, financial institutions and governments. Now, with the world's energy system more complex and interconnected than ever before, sector-specific views are no longer enough.

That's why we've redefined what's possible with Intelligence Connected: the fusion of our unparalleled proprietary data with the sharpest analytical minds, all supercharged by Synoptic AI, to deliver a clear, interconnected view of the entire value chain. Our trusted team of 2,700 experts across 30 countries breaks siloes and connects industries, markets and regions across the globe to empower our customers to identify risk sooner, spot opportunity faster and make every decision with complete confidence.

Univar Solutions Memperluas Portofolio Bahan Baku Nabati Melalui Kolaborasi Strategis dengan Roquette di Amerika Utara

Thu, 05 Nov 2026 17:43:00 +0700

Kolaborasi baru ini meningkatkan akses pelanggan ke protein nabati, serat, dan selulosa, yang mendorong inovasi di pasar kesehatan dan nutrisi

DOWNERS GROVE, Illinois, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Univar Solutions LLC ("Univar Solutions" atau "Perusahaan"), penyedia solusi global terkemuka bagi pengguna bahan baku khusus dan esensial, mengumumkan hubungan distribusi baru antara unit bisnisnya, Foodology by Univar Solutions, dan Roquette, pemimpin global dalam bidang bahan baku nabati.

Perjanjian ini mencakup perluasan portofolio selulosa, serta protein nabati NUTRALYS dan serat larut NUTRIOSE . Perluasan ini semakin memperkuat penawaran produk nabati unit bisnis Foodology by Univar Solutions bagi pelanggan di Amerika Serikat dan Kanada.

"Bersama Roquette, pelopor global dalam bidang bahan baku nabati, kami menepati janji kami untuk menghadirkan solusi inovatif dan berkelanjutan bagi pelanggan kami," ujar Aaron Lee, senior vice president bidang Kesehatan & Nutrisi di Univar Solutions. "Kolaborasi kami di Amerika Utara kini tidak hanya mencakup produk selulosa, tetapi juga protein nabati dan serat. Kami memadukan kepemimpinan Roquette dalam inovasi pangan dengan keunggulan rantai pasok dan intelijen pasar kami untuk turut membentuk masa depan nutrisi. Melalui kolaborasi ini, kami mewujudkan komitmen Feeding Healthy Tomorrows (Turut Menutrisi Masa Depan yang Lebih Sehat) melalui langkah nyata secara bertahap dalam setiap proyek."

Protein kacang polong NUTRALYS merupakan lini bahan protein nabati serbaguna yang dihasilkan dari kacang polong kuning non-GMO melalui proses berbasis air yang dipatenkan oleh Roquette. Serat larut NUTRIOSE yang berasal dari gandum atau jagung non-GMO memiliki cita rasa netral sehingga tetap mempertahankan cita rasa asli produk. Serat ini juga memiliki toleransi pencernaan yang telah terbukti secara klinis serta stabilitas yang sangat baik selama proses pengolahan. Portofolio produk selulosa ini mencakup METHOCEL, WELLENCE, ETHOCEL, TABULOSE, dan MICROCEL, yang memungkinkan pelanggan menghadirkan tekstur, stabilitas, kinerja pengolahan, serta pengalaman konsumen dalam berbagai aplikasi pangan. Dengan keahlian lebih dari 90 tahun, Roquette berada di garis terdepan dalam inovasi pangan dan nutrisi serta memelopori pengembangan solusi pangan nabati yang lebih sehat dan berkelanjutan.

"Kami senang dapat memperluas kolaborasi dengan Univar Solutions, yang kini tidak hanya mencakup produk selulosa, tetapi juga protein nabati dan serat," ujar Gaetan Fauvarque, Head of Global Distribution Management untuk Unit Bisnis Nutrisi dan Bioindustri Roquette. "Perluasan hubungan ini akan menghadirkan lebih banyak produk kami bagi pelanggan di Amerika Utara. Bersama-sama, kami dapat mengoptimalkan kekuatan masing-masing untuk menghadirkan solusi nabati yang inovatif kepada lebih banyak pelanggan. Kolaborasi ini juga memungkinkan kami memenuhi kebutuhan industri pangan dan nutrisi yang terus berkembang dengan lebih baik."

Portofolio ini dapat digunakan dalam berbagai produk makanan dan minuman, termasuk minuman berprotein, makanan ringan yang difortifikasi, diet nabati, produk roti dan kue, serta alternatif daging. Portofolio ini juga sejalan dengan tren pasar utama, seperti fortifikasi protein, diet nabati, terapi pengelolaan berat badan, dan peningkatan asupan serat. Dengan fokus yang kuat pada nutrasetikal dan nutrisi olahraga, bahan-bahan baru dalam portofolio ini juga membantu konsumen menerapkan dan mempertahankan gaya hidup yang lebih sehat.

Pelajari cara Foodology by Univar Solutions membantu berbagai merek mengantisipasi perubahan preferensi konsumen dengan menyediakan bahan baku berkualitas tinggi dan resep inovatif.

Tentang Univar Solutions

Univar Solutions merupakan distributor global terkemuka untuk bahan baku dan bahan kimia khusus, yang mewakili portofolio premium dari para produsen terkemuka di dunia. Didukung oleh salah satu armada transportasi milik sendiri dan tim penjualan teknis terbesar di industri, keahlian teknis tentang logistik yang tak tertandingi, pengetahuan mendalam tentang pasar dan regulasi, kemampuan formulasi dan pengembangan resep, serta perangkat digital terdepan, Perusahaan memiliki posisi kuat untuk menawarkan solusi khusus dan layanan bernilai tambah untuk berbagai pasar, industri, dan aplikasi. Dalam mewujudkan tujuannya untuk membantu menjaga masyarakat tetap sehat, terpenuhi kebutuhan pangannya, bersih, dan aman, Univar Solutions berkomitmen membantu pelanggan dan pemasok berinovasi serta berfokus pada semangat Tumbuh Bersama. Pelajari lebih lanjut di univarsolutions.com.

Tentang Roquette

Roquette merupakan pemimpin global dalam solusi nabati berkelanjutan serta mendorong inovasi yang membentuk masa depan nutrisi, kesehatan, dan bioindustri. Perusahaan ini memanfaatkan sumber daya alam seperti gandum, jagung, rumput laut, dan selulosa untuk menghasilkan bahan baku berkinerja tinggi yang digunakan dalam makanan sehari-hari, obat-obatan oral, produk biofarmasi canggih, serta berbagai produk berbasis hayati. Sebagai perusahaan milik keluarga dengan keahlian selama lebih dari 90 tahun dan 11.000 karyawan, Roquette melayani klien di lebih dari 150 negara serta berkomitmen menciptakan nilai jangka panjang bagi pelanggan, pasien, konsumen, dan masyarakat. Bersama-sama, kami mengubah potensi alam menjadi berbagai kebutuhan esensial bagi kehidupan. Temukan informasi selengkapnya tentang Roquette di sini.

Pernyataan Berwawasan ke Depan dan Informasi

Komunikasi ini memuat "pernyataan berwawasan ke depan" berdasarkan hukum yang berlaku tentang aspek keuangan dan operasional yang terkait dengan bisnis Perusahaan. Pernyataan berwawasan ke depan umumnya dapat dikenali dari penggunaan kata-kata seperti "meyakini," "memperkirakan," "mungkin," "akan," "seharusnya," "dapat," "berupaya," "bermaksud," "berencana," "mengestimasi," "mengantisipasi," atau istilah sebanding lainnya. Seluruh pernyataan berwawasan depan yang disampaikan dalam komunikasi ini dibatasi oleh pernyataan kehati-hatian ini.

Pernyataan berwawasan ke depan mengandung berbagai risiko dan ketidakpastian yang diketahui maupun tidak diketahui, yang sebagian besar mungkin berada di luar kendali Perusahaan, yang dapat menyebabkan ekspektasi tidak tercapai atau dapat berdampak secara signifikan dan merugikan terhadap bisnis, kondisi keuangan, hasil operasi, atau arus kas Perusahaan. Meskipun pernyataan berwawasan ke depan didasarkan pada asumsi yang dianggap wajar oleh manajemen, kami mengingatkan bahwa informasi berwawasan ke depan yang disajikan dalam komunikasi ini bukan merupakan jaminan atas peristiwa atau hasil di masa mendatang, dan bahwa peristiwa atau hasil aktual dapat berbeda secara signifikan dari hal-hal yang dinyatakan secara tersurat maupun tersirat oleh informasi berwawasan ke depan yang dimuat dalam komunikasi ini.

Untuk informasi tambahan mengenai faktor-faktor yang dapat memengaruhi Perusahaan, silakan lihat laporan tahunan terbaru Perusahaan dan laporan keuangan lainnya, termasuk informasi yang tercantum dalam bagian berjudul "Risk Factors" (Faktor Risiko). Setiap pernyataan berwawasan ke depan hanya mencerminkan pandangan Perusahaan pada tanggal komunikasi ini dan tidak boleh dianggap sebagai menggambarkan pandangan Perusahaan pada tanggal setelahnya dan Perusahaan tidak berkewajiban untuk memperbarui pernyataan berwawasan ke depan apa pun, kecuali sebagaimana diwajibkan oleh hukum.

Route du Rhum-Destination Guadeloupe, first major solo test for Boris Herrmann and Malizia 4

Thu, 05 Nov 2026 17:38:00 +0700

MONACO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- At 13:02, in bright sun and a light 8-knot breeze, Yacht Club de Monaco member Boris Herrmann set off from Saint-Malo on Malizia 4 at the start of the 3,452-nautical-mile Route du Rhum-Destination Guadeloupe to Pointe-a-Pitre.

For his third entry in this legendary transatlantic race, held every four years since 1978, it is a new challenge for the German skipper as it is the first solo race aboard Malizia 4 that was only launched in July. Among the 115 competitors, including 22 in the IMOCA fleet, he was lying in fifth place in his class as they left Saint-Malo behind them.

First big solo test for Boris Herrmann and Malizia 4

After two years of design and build, Malizia 4 was launched in Lorient in July 2026. Since then the new IMOCA has crossed the Atlantic twice in its first fully crewed race, The Ocean Race Atlantic in September from New York to Lorient when Boris and his crew finished 4th, just five minutes off the podium. The Route du Rhum is the first major solo test, a discipline he particularly enjoys: "Racing solo helps me build a connection with the boat. When you're alone, you can listen more closely to it and really feel every wave and every gust," he explained before the start.

"I feel really good and have great faith in both the boat and the team. Everyone has done an amazing job, and I am very grateful to the team and our partners for their commitment. From design through to construction, Malizia 4 already seems very reliable. I look forward to discovering everything we can achieve with it".

For YCM Vice-President Pierre Casiraghi, co-founder of Team Malizia, this first transatlantic solo challenge is a chance to better gauge the boat's potential: "The Route du Rhum will allow us to see how Malizia 4 performs over a long period with only one sailor on board. The boat was designed to be more versatile than its predecessor, particularly when sailing upwind or in lighter winds, while still maintaining excellent foiling capabilities when conditions get tough".

A very competitive IMOCA fleet

With 22 boats competing in the IMOCA class, the race promises to be highly competitive. Boris Herrmann will be up against a strong field including Maxime Sorel (Vaincre la Mucoviscidose), Francesca Clapcich (11th Hour Racing) and J?r?mie Beyou (Charal). Meanwhile, Violette Dorange, skipper of Initiatives-C?ur, damaged her starboard foil following a collision with Romain Pilliard's trimaran Use It Again off the island of Br?hat. Both skippers were forced to divert from their course.

The German skipper has a clear objective but is aware he still needs to get to grips with his new boat. "My official goal is to finish in the top six. Some competitors have been preparing for this race for two years and know their IMOCAs inside out. For us, we still need to learn how to get the best out of this new boat. A new boat generally takes one to two years to reach its full potential. We'll see if we can surprise everyone".

Weather key to strategy

This edition looks set to be very tactical as a low pressure system in the central Atlantic is disrupting the usual trade wind patterns, potentially leading contestants to opt for a more northerly route before heading down to the Antilles. "At the moment, there is no obvious route south. Conditions are unusual and might favour a more northerly route to seek out low pressure systems and passing weather fronts," says Boris Herrmann.

The first IMOCA boats are expected to arrive in Guadeloupe in 10 to 12 days. Interpreting the weather, managing the boat, and maintaining a consistent pace will be the decisive factors all the way to Pointe-a-Pitre.

Setting a course for 2027 and the Vendee Globe

This Route du Rhum is another milestone in Team Malizia's preparation. After the transatlantic crossing, Malizia 4 heads to Alicante, where the team regroups for The Ocean Race 2027, before continuing their preparations for the 2028?2029 Vend?e Globe. With this programme, Boris Herrmann continues his commitment to offshore racing through a project that combines sporting achievement, innovation, scientific research and raising awareness on climate issues. Today, the priority is to cross the Atlantic and reach Pointe-a-Pitre.

FIT House of Brands Launches Limited-Time Incentive for US Multi-Unit Franchise Partners as Global Growth Accelerates

Thu, 05 Nov 2026 17:34:00 +0700

F45 Training and FS8 invites entrepreneurs to commit before year-end, following strong Q3 studio openings and F45's launch in Colombia, its 58th country

Austin, TX, Nov. 04, 2026 (GLOBE NEWSWIRE) -- FIT House of Brands, the parent company of F45 Training, FS8, and VAURA Pilates, today announced 25 new studio openings across 7 countries in the third quarter of 2026, alongside F45 Training's official launch in Colombia, the brand's 58th country.

The momentum sets the stage for an aggressive US and global growth push in 2027, as the company invites new and existing franchise partners to grow with two of fitness's most recognized boutique brands.

FIT House Q3 highlights:

25 new studios opened globally, bringing the network to nearly 1,500 studios in 58 countries

16 new FS8 studios, including FS8 South McKinney in Texas, opened in July by first-time franchise owners, and more US openings in New York City and Malibu

Key F45 openings in California, North Carolina, and Texas

VAURA Pilates reached 10 studios worldwide with its first studio in Indonesia, in Jakarta's Menteng district, with four more US locations on the way in San Mateo, CA; Boston, MA; Tampa, FL; and Prosper, TX

FIT House gives franchise partners something few fitness franchisors can: two distinct, proven boutique formats under one roof. F45 Training delivers 45-minute functional group training, while FS8 combines Pilates, strength, and yoga in one studio experience. Franchise owners can open two of the same brand or pair one of each, serving different members within the same market that each have unique personal fitness goals.

"This is the time to be an entrepreneur in fitness. Q3 proves that demand for F45 Training and FS8 is global and growing, and our partners in Colombia are seizing that momentum and moving fast," said Tom Dowd, CEO, FIT House of Brands. "In the US, there is still enormous white space for both F45 Training and FS8. When paired with our business model and modalities, a multi-unit portfolio amplifies that growth opportunity, both for the operator and the communities they serve."

This fall, F45 Training opened its first Colombian studio in Bogot?'s La Cabrera neighborhood. The franchise group, led by local partner Johan Cediel, plans to open additional studios across Bogot?, before expanding to Medell?n, Barranquilla, and other additional markets.

"Opening in Bogot? is the first step in our long-term strategy, which is why we're planning more locations in the city before moving into other markets. We want to grow F45 Training in Colombia by building a community around training, technology and an experience that helps people reach their goals," said Johan Cediel, General Manager, F45 Training Colombia.

To support operators ready to scale, FIT House is offering a limited-time incentive for prospective franchise partners who sign for two studios before December 31, 2026. The offer applies to two F45 Training studios, two FS8 studios, or one of each, and significantly reduces upfront investment. Interested candidates can inquire at functionalinspiredtraining.com.

About FIT House of Brands

FIT (Functional Inspired Training) House of Brands is a global fitness franchise company with a network of nearly 1,500 studios across 58 countries. FIT provides franchisees with established business models, operational support, and structured training programs across its house of brands:

F45 Training: A global leader in functional fitness, offering 45-minute team-based workouts that combine strength, cardio, and scientifically backed programming to build strength, improve endurance, and enhance longevity.

FS8: FS8 fuses Pilates, Tone, and Yoga into a seamless, low-impact workout. Built on eight science-backed elements, FS8 is designed to enhance strength, flexibility, and mental well-being. The experience is dynamic yet restorative, offering a fresh take on fitness in an inclusive, community-driven environment.

VAURA Pilates: A sensory-driven reformer Pilates experience that blends precision and athletic training in an immersive environment. With neon lights, mirrored ceilings, and upbeat music, VAURA energizes both body and mind, creating a workout that feels as powerful as it is effective.

Recovery: A suite of solutions, including cold plunge, infrared sauna, and percussion therapy, designed to optimize recovery and performance.

FIT is committed to building a sustainable and scalable global franchise network that empowers people to move better, feel stronger, and live longer. For more information, visit www.functionalinspiredtraining.com or follow us on LinkedIn (@FunctionalInspiredTraining) and YouTube (@FunctionalInspiredTraining).

DISCLAIMER: This information is not intended as an offer to sell, or the solicitation of an offer to buy, a franchise. It is for information purposes only. Certain countries and states require that an offer of a franchise can be made only through the delivery of a Franchise Disclosure Document ("FDD").

If you are a resident of one of those countries states, are receiving this message in one of those countries or states or intend to operate a franchise in one of those countries or states, we will not offer you a franchise unless and until we have complied with any applicable pre-sale registration and we have complied with disclosure requirements in the applicable jurisdiction.

Denodo Named a Leader in the 2026 Gartner Magic Quadrant for Data Integration Tools for Seven Consecutive Years

Thu, 05 Nov 2026 07:45:00 +0700

Denodo believes this recognition is due to the strength of its agentic AI support and the loyalty of its diverse customer base

PALO ALTO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Denodo, the AI data layer company, today announced that Gartner has positioned the Company as a Leader, for the seventh consecutive year, in its Magic Quadrant for Data Integration Tools.

"Data integration tools remain a foundational data architecture component for supporting operational, analytical, and AI use cases," states Gartner. "This research analyzes 19 vendors to help data and analytics leaders make informed technology decisions."

The complete and complementary Magic Quadrant report, published on November 2, 2026 and authored by Thornton Craig et al., is available here.

"By 2028, 60% of data integration tasks will be completed autonomously, freeing up 20% of data engineers' time," says Gartner in the 2026 Magic Quadrant report.

Since the publication of last year's Gartner Magic Quadrant for Data Integration Tools report, the award winning Denodo Platform has made significant enhancements in data integration automation. In March, Denodo released Denodo Platform 9.4, enabling AI systems, applications, and users to reliably access live data, understand business context, and operate with strong performance within clear governance boundaries, and in July, Denodo released Denodo Platform 9.5, providing active context for trustworthy agentic AI.

"The goals of data integration are now driven by the needs of agentic AI, which is for AI-ready data that is immediately integrated, governed, and supported by active context. The Denodo Platform, by establishing the critical AI data layer, provides the most flexible, direct foundation for trustworthy, AI-ready data, in support of advanced automation," said Ravi Shankar, senior vice president and chief marketing officer at Denodo. "We are extremely proud that Gartner has once again recognized Denodo as a Leader in the Magic Quadrant for Data Integration Tools, as Gartner has done for the previous six years. This strengthens our conviction that an overarching, cross-platform AI data layer, with active context, provides the most effective foundation for tackling complex challenges with autonomous AI."

On the Gartner Peer Insights platform, the Denodo Platform currently has a 4.6 average rating out of a possible 5, from a total of 337 ratings as of November 2026. In the words of Denodo customers:

"Productivity Doubles and Delivery Times Improve with Enhanced Semantic Layer Features: Increased developer productivity by more than twice over conventional ETL coding. Improved delivery times to the business. Perfect semantic layer insulating the business from the ever-changing data landscape. Virtual views reduce cloud footprint, resulting in cost savings." - IT Manager, Insurance

"Denodo Enhances Enterprise Data Integration with Robust Security and Easy API Creation as well as Data Governance: Denodo is a strong and mature data virtualization platform that significantly enhances our enterprise data ecosystem. It allows multiple data sources, structured as well as unstructured, in a single place. In Denodo we can easily apply row-level or column-level security within seconds. In Denodo data analysts can easily access Denodo views to play with data, and it's easy for them to understand the data flow with the help of tree structures and data lineage. We can easily create APIs in Denodo, with data security, so APIs can be consumed by other applications. Denodo has advanced level cost-based optimization features for performance, to automatically pick the best plan. We can create rules to handle APIs and other traffic. It provides a diagnostic and monitoring tool for real-time data monitoring. The data catalog is a very useful feature for business users, so they can directly research data, and it also helps data analysts. It has multiple features like data integration, API creation, data security, data governance, and performance optimization." - IT Professional, Manufacturing

Gartner, Magic Quadrant for Data Integration Tools, Thornton Craig, Robert Thanaraj, Sharat Menon, Jenna Goodrich, Nina Showell, 2 November 2026.

Gartner, Gartner Peer Insights 'Voice of the Customer': Data Integration Tools, 30 June 2026

Gartner Disclaimers

Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.

Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates.

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner's business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.

Cyberport Venture & Capital Forum 2026 Grand Opening

Thu, 05 Nov 2026 07:39:00 +0700

Source: Cyberport

*Cyberport Community Cumulative Funding Surpasses HK$74.5 Billion, Welcoming 19 Listed Companies and 2 Unicorns over the Past Year

*Cyberport Investors Network (CIN) Celebrates 9th Anniversary, Facilitating Over HK$6 Billion in Cumulative Funding

*Cyberport Signs MoUs with Gobi Partners and Thailand's National Innovation Agency to Unlock Global Growth Corridors

HONG KONG SAR - Media OutReach Newswire - 4 November 2026 - The annual flagship event Cyberport Venture & Capital Forum 2026 (CVCF) officially opened today at Hong Kong Cyberport.

The two-day forum, themed "Scaling in a Changing World: Winning the Next Competitive Cycle", brings together over 80 influential global venture capitalists, entrepreneurs and industry leaders to explore new frontiers in global venture trends, capital rerouting, Enterprise and Agentic AI, One-Person Companies (OPCs), digital assets, frontier technologies, and tokenisation economy, aiming to spotlight Hong Kong's unique position as a strategic gateway connecting the Chinese Mainland, ASEAN, the Middle East, Central Asia and global innovation and funding networks. The forum also showcases the latest fundraising achievements of Cyberport start-ups.

The forum was inaugurated by Lillian Cheong, Acting Secretary for Innovation, Technology and Industry and Simon Chan, Chairman of Cyberport, and other distinguished guests at the opening ceremony, marking the official start of this global forum.

Lillian Cheong, Acting Secretary for Innovation, Technology and Industry, said "Turning AI potential into sustainable growth requires more than technology. It also requires investment, business expertise and access to markets. This is where today's forum can make a difference - bringing innovators and investors together to explore emerging technologies, support promising ventures and open doors to new opportunities. The HKSAR Government will continue to strengthen the support that helps promising ventures grow as well its investment to mobilise more private capital, consolidating Hong Kong's position as an international innovation and technology centre, and as a premier hub for AI."

Simon Chan, Chairman of Cyberport, said: "In a shifting global capital landscape, Hong Kong's role as a 'super-connector' and 'super value-adder' between the Chinese Mainland and the world is more valuable than ever. The cross-border dialogue and partnerships forged here will create fresh opportunities for innovation, investment and collaboration."

Cyberport Start-ups Show Robust Fundraising as AI and the Agentic Economy Take Centre Stage

Cyberport's start-ups have demonstrated robust fundraising performance over the past year. Cyberport gathers over 2,400 companies, Cyberport start-ups have raised over HK$74.5 billion in funding. During the year, Cyberport proudly welcomed 19 listed companies and 2 unicorns to its community. Recent high-value fundraising rounds include Finloop, Qupital and Premialab, leverage AI, blockchain and digital assets - reflecting sustained market confidence in these emerging technologies and underscoring Cyberport's success in fostering their development.

CIN Celebrates 9th Anniversary, Connecting Global Capital with High-Potential Start-ups

As Hong Kong's digital tech hub, AI accelerator and key incubator, Cyberport actively connects global investors with start-ups through diverse funding channels.

The CIN 9th Anniversary Celebration commemorated a successful nine-year milestone while ushering in a new chapter of leadership, as the chairmanship passed from Hendrick Sin to John Ng. To honour this pivotal handover, Hendrick Sin, Hon. Duncan Chiu, and Cindy Chow were officially designated as Honorary Chairs of CIN in recognition of their distinguished contributions to the ecosystem.

Hendrick Sin, Honorary Chair of CIN; Co-Founder of CMGE Technology Group Limited; Chairman of China Prosperity Capital, stated in his video speech, "CIN has facilitated over HK$6 billion in investments across more than 130 projects since its inception, reflecting strong investor confidence in Cyberport companies.

Looking ahead, we will strengthen the quality and depth of our deal flow, enhance structured capital partnerships to broaden access to funding at different growth stages, and deepen our relationships with CVCs, PE firms, family offices and LPs, further diversifying CIN's investor network. Through these efforts, CIN will continue to connect promising companies with the right capital, expertise and networks needed to scale and succeed.

John Ng, Chairman of CIN, added in his speech, "I'm honoured to be appointed Chairman of CIN. The network has grown to nearly 250 investment firms, an achievement that reflects the tremendous efforts of Hendrick and the CIN team over the past years. Drawing on my background in corporate venture capital and family offices, one of my priorities will be to expand CIN's network within these communities and take CIN into its next chapter."

Another key financing channel, CMF, has invested in 30 start-up projects as of September 2026, with total investment including co-investments exceeding HK$2.7 billion and a co-investment ratio of over 1:9.3. Further augmenting ecosystem liquidity, Cyberport, BOCHK Asset Management and BOC Group Investment formed a strategic partnership in May 2026, as well as with Taiping Financial Holdings in Aug 2026 on venture capital funds to back promising Hong Kong I&T start-ups.

Strategic Partnerships to Unlock Global Growth Corridors

At the Forum, Cyberport signed two Memorandums of Understanding (MoUs), with Gobi Partners and with Thailand's National Innovation Agency (NIA), to solidify global corridors for cross-border expansion.

Cyberport and Gobi Partners signed a Memorandum of Understanding (MoU) to deepen collaboration in nurturing innovation and technology enterprises, facilitating market expansion and investment opportunities, and strengthening the innovation ecosystems of Hong Kong, Asia and the Middle East.

Building on a longstanding partnership, Gobi has invested in more than 24 Cyberport companies, including CMF co-investments. Witnessed by Lillian Cheong, Acting Secretary for Innovation, Technology and Industry, Simon Chan, Chairman of Cyberport, and Chibo Tang, Managing Partner, GBA Team of Gobi Partners, the MoU was signed by Dr Rocky Cheng, CEO of Cyberport, and Fred Li, Managing Director, GBA Team of Gobi Partners.

Meanwhile, Cyberport and Thailand's National Innovation Agency (NIA) signed an MoU to promote cross-border innovation collaboration, startup development and knowledge exchange in AI, smart city and other digital technologies. It will cover soft-landing and market expansion, business matching, innovation programmes and community engagement, joint events, and proof-of-concept and pilot opportunities. The MoU was witnessed by Lillian Cheong, Acting Secretary for Innovation, Technology and Industry, Simon Chan, Chairman of Cyberport, and Preechaya Panyakrua, Innovation Counsellor of NIA, and signed by Dr Rocky Cheng, CEO of Cyberport, and Dr Krithpaka Boonfueng, Executive Director of NIA.

Decoding the New Playbook for Scaling in the Age of AI

This year's CVCF programme is organised around three umbrella themes: Mega Trends & AI Frontiers, Regional Market Focus & Global Corridors, and Market Focus & Strategic Capital Dynamics.

Opening the main stage, Mahesh Krishnaswamy, Founder and CEO of Taara, delivered the keynote "The Innovation Playbook: Capitalizing on Moonshots and Faster Cycles in the Age of AI", sharing how Taara evolved from a radical moonshot into a real-world high-speed optical communications solution - a timely lens on compressed innovation cycles and how breakthrough technology scales.

The forum also brought together venture capital leaders from Gobi Partners, Alumni Ventures, Rasmal Ventures, Primavera Capital, Draper Dragon, Pegasus Tech Ventures, Plug & Play and more to examine AI-driven capital shifts, high-growth corridors across the Middle East, ASEAN and the Greater Bay Area, and how public-private and corporate strategic capital can accelerate tech scale-ups.

Beyond the thought leadership sessions, the event further reinforced Cyberport's role in connecting capital, innovation and global market opportunities. It also provided a dynamic platform for business matching and startup empowerment. This year's Founder Pitch attracted strong interest from local and international venture capital firms, enabling startups from early-stage innovators to high-growth scale-ups to present their cutting-edge solutions to investors and ecosystem partners.

Throughout the first day, the event floor featured tailored Investor Matching sessions, dynamic Innovator Showcases featuring elite, high-potential startups across key tech sectors from local and global partner networks, and dedicated Startup Clinics offering practical strategic guidance. Coupled with engaging networking exchanges, Day one concluded on a positive note, reinforcing Cyberport's ongoing role in connecting capital, innovation, and global market opportunities.

Day two will feature the CVCF's spotlight event "Agentic Economy Summit", themed "Intelligent Frontiers, Tokenised Horizons", featuring a keynote address by Joseph Chan, Under Secretary for Financial Services and the Treasury, and will explore how agentic AI is reshaping business and how digital assets are redefining the way value moves. The summit will examine digital identity, institutional tokenisation, HKD stablecoins, programmable payments and machine-to-machine commerce, alongside the rise of OPCs. Day two also features hands-on startup workshops designed to equip founders with practical playbooks for pitch mastery and market scaling.

For more information on Cyberport Venture & Capital Forum 2026 and the speaker line-up, please visit http://cvcf.cyberport.hk/.

About Hong Kong Cyberport

Wholly owned by the Hong Kong Special Administrative Region (HKSAR) Government, Cyberport is Hong Kong's digital tech hub and AI accelerator, with a vision to empower industry digitalisation and intelligent transformation, to promote digital economy and AI development, and to foster Hong Kong to be an international AI, innovation and technology (I&T) hub. Cyberport gathers over 2,400 companies, including 30 listed companies and 10 unicorns. 40% of onsite companies' founders come from 28 countries and regions, while Cyberport companies have expanded to over 36 global markets.

Cyberport, with Hong Kong's largest AI Supercomputing Centre and AI Lab as the engine, has been building the AI ecosystem with industry-leading AI companies and over 500 AI and data science start-ups. Through development of tech clusters, namely AI, data science, blockchain and cybersecurity, Cyberport empowers industries across smart city and government, banking and finance, digital entertainment, culture and tourism, healthcare, education and training, property management, construction, transportation and logistics, green environment and more, while hosting Hong Kong's largest FinTech community.

Commissioned by the HKSAR Government, Cyberport has implemented proof-of-concept and sandbox schemes, subsidisation for digital tech adoption, industry tech training and start-up incubation, to drive technology R&D, translation and commercialisation, thus propelling digital transformation and intelligent upgrade across industry and society.

Also as "State-level Scientific and Technological Enterprise Incubator" and Hong Kong's key incubator, Cyberport supports entrepreneurs with funding and office space, extensive networks of enterprises, investors, technology corporations and professional services for business growth and expansion to Chinese Mainland and overseas markets, all-round facilitation for landing in Hong Kong, talent attraction and cultivation, ready as a launchpad to take start-ups in any stages of development to the next level.

For more information, please visit https://www.cyberport.hk/en.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Cyberport

"Study in Beijing" Education Exhibition 2026 Held in Greece and Cyprus

Thu, 05 Nov 2026 07:35:00 +0700

A Scene of the exhibition

Source: Beijing International Education Exchange Center

ATHENS, GREECE - Media OutReach Newswire - 4 November 2026 - Recently, the "Study in Beijing" Education Exhibition 2026, hosted by the Beijing Municipal Education Commission and organized by the Beijing International Education Exchange Center and other institutions, was held successively at the Athens University of Economics and Business in Greece and the University of Cyprus.

A delegation of 11 Beijing universities, including Renmin University of China, Beijing Normal University, and Beihang University, participated in the exhibition, showcasing Beijing's higher education resources and achievements in international education to local faculty, students, parents, and education professionals.

This year marks the 20th anniversary of the establishment of the China-Greece comprehensive strategic partnership. At the opening ceremony of the Greek stop of the "Study in Beijing" Education Exhibition, Fang Qiu, Chinese Ambassador to Greece, delivered a welcome speech to the Beijing education delegation.

Li Yi, Director of the Beijing Municipal Education Commission, introduced the strengths and cutting-edge programs of Beijing universities and invited young people from Greece and other parts of Europe to study in Beijing. Nancy Pouloudi, Vice Rector of the Athens University of Economics and Business, delivered a speech, and Alexandros Papalexandris, Greek Director of the Business Confucius Institute at the Athens University of Economics and Business, shared practices in China-Greece language and cultural exchange.

The year 2026 marks the 55th anniversary of the establishment of diplomatic relations between China and Cyprus, and the 5th anniversary of the establishment of the China-Cyprus strategic partnership. In recent years, educational cooperation between the two countries has continued to advance, with steady progress in key areas such as higher education exchanges, mutual recognition of academic degrees, and Chinese language teaching.

Yang Yundong, Chinese Ambassador to Cyprus; a senior representative of the Cyprus Ministry of Education, Sport and Youth; and Professor Tasos Christofides, Rector of the University of Cyprus, attended the education exhibition and delivered speeches. George Solomonides, a representative of Cypriot students studying in China, shared his experiences and reflections from studying in Beijing.

Beijing is home to nearly 100 universities and research institutions that can enroll international students, and continues to offer diversified educational programs, scholarship support, and internship and entrepreneurship services centered on the themes of "Understanding Beijing, Studying in Beijing, Integrating into Beijing, and Staying in Beijing."

At the exhibition, participating universities set up booths according to their disciplinary strengths, covering fields such as aerospace, rail transit, energy and power, teacher education, international Chinese language, mathematics and humanities, food and business, tourism management, special education, and Olympic education. Local students and parents inquired about admission policies, program offerings, scholarship applications, and student life.

During the event, ceremonies were also held in the two locations for the designation of student-source base schools and the signing of sister-school agreements, promoting the establishment of regular mechanisms between the two sides in areas such as student recruitment, inter-school collaboration, teacher education, and youth exchanges.

Currently, Beijing hosts 65,800 international students from 183 countries and regions, and ranks 12th globally in the QS Best Student Cities 2027 ranking.

The issuer is solely responsible for the content of this announcement.

HP Inc. Appoints Emma Walmsley as Chief Executive Officer

Thu, 05 Nov 2026 07:28:00 +0700

Bruce Broussard to Succeed Chip Bergh as Chair of the Board

PALO ALTO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) today announced that its Board of Directors has unanimously appointed Emma Walmsley as Chief Executive Officer, effective January 4, 2027. Ms. Walmsley most recently served as Chief Executive Officer of GSK and has been a member of Microsoft's Board of Directors for seven years.

She will succeed Bruce Broussard, who has served as Interim Chief Executive Officer since February 2026. Broussard will become Chair of the Board effective January 4, 2027, succeeding Chip Bergh.

"HP has tremendous potential at an important inflection point in technology, and we need a leader who can build on our innovation heritage and strengths to boldly shape the company's future. Emma is a proven CEO with a track record of leading organizations at scale and guiding them through significant change. She has the experience and skills to bring HP's businesses, capabilities and people together to capture the opportunities ahead as AI moves to the edge, transforming how we work and live in a more connected world. I look forward to supporting her as she leads HP into its next phase of growth," said Bruce Broussard, Interim Chief Executive Officer.

"HP is an iconic company with a defining role in shaping the future of work on a global scale. I'm excited to join the team and, together, move forward with clarity and conviction. We will focus on harnessing the power of the AI era and putting HP's creativity and innovation to work to unlock new sources of growth and deliver lasting value for our customers, shareholders, partners and people," said Emma Walmsley.

"Today's appointment follows a comprehensive global search focused on what HP needs to win in its next chapter. Throughout the process, Emma stood out for the strength of her leadership experience across multiple industries, the clarity of her strategic thinking and her ability to translate customer insights into new growth. She has a people-first leadership approach that aligns and inspires high-performing teams around clear priorities, strong execution and lasting value creation," said Chip Bergh, Chair of the Board.

"I also want to thank Bruce for his strong leadership, which has enabled the Board to conduct an intentional and rigorous search leading to today's successful outcome. It's a privilege to hand the role of Chair to him, knowing he will provide important continuity and valuable guidance to Emma and the Board during the transition and in the years ahead," said Bergh.

Ms. Walmsley is the former Chief Executive Officer of GSK, where she served from April 2017 through December 2025. During her nearly nine years as CEO, she led a significant transformation of the global biopharmaceutical company and delivered a step-change in its operating performance. She sharpened the company's strategic focus on specialty medicines and vaccines, reinvigorated its R&D pipeline and strengthened the balance sheet following the successful separation of its consumer healthcare business, while enhancing GSK's leadership bench and succession pipeline. Ms. Walmsley joined GSK in 2010 and became CEO of GSK Consumer Healthcare in 2015 before being appointed Group CEO. Earlier, she spent 17 years at L'Or?al building and leading major global consumer businesses.

Bergh has served as Chair of HP's Board since 2017 and as a director since 2015 and will continue as Chair until Broussard assumes the role on January 4, 2027.

"Chip has provided strong leadership as Chair for the past nine years, helping guide HP through significant change while maintaining a sharp focus on governance, capital allocation and value creation," said Broussard. "I have appreciated his partnership while serving as Interim CEO."

About HP Inc.

HP Inc. (NYSE: HPQ) is a global technology leader redefining the Future of Work. Operating in more than 180 countries, HP delivers innovative and AI-powered devices, software, services and subscriptions that drive business growth and professional fulfillment. For more information, please visit: HP.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations and assumptions, including, but not limited to, the statements regarding HP's executive succession plans and Board Chair transition.

These forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and actual results may differ materially from any future results expressed or implied by the forward-looking statements, including our ability to transition to a new CEO and the other factors described in the Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and HP's other filings with the Securities and Exchange Commission.

The forward-looking statements in this press release are made as of the date of this document and HP assumes no obligation and does not intend to update these forward-looking statements.